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ABSTRACT

Abuse and addiction to psychostimulants such as cocaine and methamphetamine
present a worldwide health issue. Although the molecular mechanisms that mediate the
effects of these drugs are well characterized, the underlying genetic basis of variation in
differing responses to drugs of abuse are largely unknown. The Drosophila
melanogaster model system can be used to identify genetic and transcriptional networks
that underlie variation in effects of drug exposure that can serve as a blueprint for
subsequent studies on humans. Drosophila possess a dopamine transporter to which
cocaine and methamphetamine bind, and exhibit many of the effects that are observed
in humans when cocaine and methamphetamine are consumed. Here, we use
Drosophila to identify the underlying genetic and neurobiological factors that contribute
to cocaine and methamphetamine use. Specifically, we identified genes and genetic
networks with human orthologs that contribute to variation in consumption of and
preference for cocaine and methamphetamine using genome-wide association analyses
in the D. melanogaster Genetic Reference Panel (DGRP) and extreme QTL mapping in
an advanced intercross population. Additionally, we performed single-cell RNA
sequencing on brains of cocaine exposed flies and constructed genetic interaction
networks from these data. Our results show that response to cocaine and
methamphetamine in flies is genetically complex, sexually dimorphic, and involves
multiple brain regions.
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INTRODUCTION

The abuse of illicit drugs creates an enormous socioeconomic problem worldwide.
Economically, drug abuse leads to greater than $740 billion lost annually in the United
States alone, due to drug enforcement, crime, lost work productivity and health care
(drugabuse.gov). The number of people and proportion of the world’s population using
drugs has increased from 210 million (4.8% of individuals aged 19-64) in 2009 to 269
million (5.3% of individuals aged 19-64) in 2018 (World Drug Report 2020). According to
the Global Burden of Disease Study, there were 42 million years of “healthy” life lost in
2017 as a result of premature death or disability, and 585,000 deaths that attribute to the
use of drugs (Global Burden of Disease Study 2017). Drug use can have a negative
impact on the social development of individuals, contributing to low educational
attainment, increased difficulty in finding employment and remaining employed, and
financial instability. These problems are expected to be exacerbated following the
economic downturn resulting from the global pandemic cause by COVID-19 with
decreases in Government drug-related budgets and economic hardships driving poor
individuals to engage in increased drug use (World Drug Report 2020).

Background

Psychostimulant mechanisms and effects

Psychostimulants are drugs that affect signaling in the brain. Euphoria and a sense of
performance enhancement through use of these drugs lead to their abuse (Favrod-
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Coune & Broers, 2010) . Two commonly abused illicit psychostimulants are cocaine and
methamphetamine. Both of these drugs target the mesolimbic reward pathway in the
brain, with a strong effect on monoaminergic systems, especially dopamine (Rothman &
Baumann, 2003; Howell & Kimmel, 2008; Favrod-Coune & Broers, 2010). The
mesolimbic reward pathway in humans begins in a part of the midbrain known as the
ventral tegmental area (VTA) with dopaminergic projections to the nucleus accumbens
(NAc) in the ventral striatum (Adinoff, 2004; Pariyadath et al., 2016). Projections from the
nucleus accumbens then travel to multiple brain regions including the amygdala,
hippocampus, and prefrontal cortex (Pariyadath et al., 2016). It is at these synapses
between the VTA and NAc that cocaine and methamphetamine act.

Cocaine acts primarily by binding to multiple monoamine transporters such as dopamine
and serotonin of presynaptic neurons, preventing the reuptake of neurotransmitters,
leading to hyperstimulation of postsynaptic neurons (Figure 1.1; Howell & Kimmel, 2008;
Favrod-Coune & Broers, 2010). Methamphetamine also binds to monoamine
transporters, blocks reuptake, reverses the function of the monoamine transporters
causing efflux of monoamines, and enters the presynaptic neuron, triggering release of
additional neurotransmitters from storage vesicles in the presynaptic neuron into the
synapse (Figure 1.1; Howell & Kimmel, 2008; Panenka et al., 2013). This increased
stimulation leads to euphoria, hyperactivity and hypersensitivity to sight, sound and
touch (Rothman & Baumann, 2003; Favrod-Coune & Broers, 2010). Taken in large
amounts, cocaine and methamphetamine can lead to restlessness, anxiety, and
paranoia (drugabuse.gov). Prolonged use of these drugs also produces long-term
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effects like heart and blood vessel damage, respiratory damage, and stroke that can
ultimately lead to death.

Figure 1.1. Cocaine and methamphetamine in the synapse. The mechanism
of action for methamphetamine (left) and cocaine (right) in the synapse of
dopaminergic neurons.
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History of cocaine and methamphetamine

Cocaine is an alkaloid derived from the coca plant, Erthroxylum coca, that is native to
northern parts of the Amazon in South America and known as “the divine plant” of the
Incas (Mortimer, 1901). Humans have used the coca bush for thousands of years, using
its leaves for teas or chewing on dried leaves, releasing cocaine in saliva to alleviate
hunger and thirst, or to relieve altitude sickness (Biondich, 2015). Cocaine was first
isolated in 1855 by Friedrich Gaedcke and purified by Albert Niemann in 1859
(https://www.pyxislabs.com). Since then, cocaine has been used as a prescription drug
for toothaches and headaches, as an ingredient in the early version of the popular
beverage Coca Cola, and as an anesthetic (Barash, 1977; Markel, 2011). Today,
cocaine is still approved by the US Food and Drug Administration (FDA) as a nasal
solution and for surgeries through the nasal cavities in adults (drugs.com). Evidence for
the addictive properties of cocaine was not realized until the early 20th century when
recreational use became popular and the first reports of nasal damage from nasal
cocaine inhalation appeared in the literature (Karch, 2005). By 1914, cocaine was
banned in the US as thousands of people were dying annually (Karch, 2005) and today
is considered a Schedule II drug by the US Drug Enforcement Agency (DEA), meaning it
is a drug with a high potential for abuse that can lead to severe psychological and
physical dependence (dea.gov).
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Methamphetamine is a man-made psychostimulant that was first synthesized in 1893 by
the Japanese scientist Nagai Nagayoshi (Yu et al., 2015), but was not widely produced
until Akira Ogata synthesized crystallized methamphetamine in 1919 (Anglin et al.,
2000). In 1971, methamphetamine use was restricted in the United States by law;
however, oral methamphetamine is still used today for therapeutic purposes including
treatment of attention deficit hyperactivity disorder (ADHD) in children and short-term
treatment of obesity (Kish, 2008). Given the high potential for abuse, methamphetamine
is also considered a Schedule II drug by the DEA (dea.gov).

History of the genetics of substance abuse

Family, adoption, and twin studies

Drug abuse and addiction are complex disorders with many genetic and environmental
factors contributing to variation in their susceptibility. The extent to which genetic factors
play a role, if any, was largely unknown up until the late 20th century when family,
adoption, and twin studies were performed to determine if drug abuse is at all heritable.
The earliest studies sought to determine this by examining the risk of substance abuse
in first-degree relatives of individuals with or without substance use disorder (Meller et
al., 1988; Merikangas et al., 1998). These studies suggest that substance use disorders
cluster in families and individuals show up to an eight-fold increased risk of drug use
disorders. Although these family studies provide evidence of increased risk within
families, they are unable to distinguish if these family ties are due to genetic or
environmental factors.
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Adoption studies allow for genetic and environmental factors to be disentangled by
comparing behavioral traits of offspring with biological (genetic) and adoptive
(environmental) parents. Early adoption studies worked to identify and isolate
environmental factors influencing the development of drug abuse. In particular, divorce
and psychiatric disorders in adoptive families were associated with increased drug
abuse (Cadoret et al., 1986, 1995). Risk for drug abuse was also elevated in adopted
offspring of biological parents with drug abuse, in biological siblings of adopted children
with drug abuse, and in adoptive siblings of adopted offspring with drug abuse (Kendler
et al., 2012). This study found that many genetic and environmental factors predict risk
for drug abuse (Kendler et al., 2012). Genetic factors include biological parent or sibling
history of drug abuse, criminal activity, and psychiatric problems, while environmental
factors include adoptive parental history of divorce, death, criminal activity, and adoptive
sibling history of drug abuse and psychiatric problems. Although adoption studies have
identified environmental factors, they have limitations like difficulty obtaining adoption
records and confounding effects that are more common in adoption situations. Namely,
biological parents who put their offspring up for adoption are more likely to suffer from
drug abuse than the general population, and adoptive parents are less likely to suffer
from drug abuse (Hall et al., 2013).

A widely used study design to determine if a trait is heritable is to compare monozygotic
(MZ) and dizygotic (DZ) twins to identify genetic and environmental effects that influence
a trait. MZ twins share 100% of their DNA while DZ twins share, on average, just 50%.
Thus, assuming both MZ and DZ twins share 100% of their family environment, if MZ
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twins show a greater similarity for a given trait than DZ twins, this provides evidence that
genes influence the trait. Twin studies have determined drug abuse to be heritable with
heritability estimates ranging from 0.3 to 0.7, depending on the substance (Grove et al.,
1990; Tsuang et al., 2001; Agrawal and Lynskey, 2008). In the Vietnam era twin sample,
Tsuang et al. reported that additive genetic effects, shared environmental factors, and
unique environmental factors significantly contribute to the risk of drug abuse (Tsuang et
al., 2001). However, there are limitations to twin studies. The assumption that MZ and
DZ twins are exposed to and respond to a 100% shared environment is unrealistic (Pam
et al., 1996; Horowitz et al., 2003; Richardson et al., 2005) and this can lead to inflated
heritability estimates. Also, twin studies can only account for genetic effects at the DNA
sequence level, failing to account for epigenetics and structural changes in the DNA.
Lastly, twin studies assume genetic and environmental factors have only a direct effect
on the trait of interest, and thus do not account for situations like gene-by-environment
interactions.

Family and adoption studies helped reveal heritable factors contributing to risk of drug
abuse, but they fail to determine how many genes are involved or the specific genes
whose influence is drug-specific versus genes that show an effect across drugs. The first
studies to attempt to identify specific genes that contribute to risk of drug abuse utilized
molecular evidence and behavioral responses of various drugs to identify candidate
genes. The focus of these candidate gene studies is primarily on specific sets of genes
based on a priori assumptions pertaining to the mechanism of actions of the specific
drugs. In the case of cocaine and methamphetamine, the focus is primarily on the
monoamine systems, with a great amount of work done on dopamine systems because
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of the role cocaine and methamphetamine play on components of the dopaminergic
reward pathway such as the dopamine transporter. To a lesser extent, serotonin and
norepinephrine systems have also seen attention. Candidate gene studies were
performed primarily in humans through association studies of candidate genes with drug
abuse phenotypes and in transgenic mouse models via direct manipulation of candidate
genes.

Human linkage/association studies

Early linkage and association studies in humans examined association of specific genes
based on a priori assumptions about the importance of genes like dopamine receptors or
the dopamine transporter in response to cocaine and methamphetamine. With the
inability to look at markers across the entire genome, these studies typically utilized only
a small number of genomic markers and did not attempt to identify additive or interactive
effects. Many of these studies have produced inconclusive or even contradicting results.
For example, some studies report an association between the dopamine D2 or D3
receptors and abuse of cocaine or methamphetamine (Noble et al., 1993; Comings et
al., 1994; Persico et al., 1996; Comings et al., 1999; Moyer et al., 2011), whereas other
studies find no association (Gelernter et al., 1999; Serý et al., 2001; Tsai et al., 2002;
Messas et al., 2005; Fernàndez-Castillo et al., 2010; Lohoff et al., 2010). Similar
contradictory results have been observed for association analyses between the
dopamine transporter (DAT) and abuse of cocaine or methamphetamine (Hong et al.,
2003; Liu et al., 2004; Guindalini et al., 2006; Fernàndez-Castillo et al., 2010; Lohoff et
al., 2010). Additionally, many studies were plagued by a multiple testing problem by
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assessing multiple markers in multiple ways. After correcting for multiple comparisons,
this caused results to be nominally significant, typically only for a few particular drug
related phenotypes (Comings et al., 1994, 1999; Persico et al., 1996; Ide et al., 2004).
These results suggest the effect of any genetic variant may be small for any given
phenotype and some variants are specific to subphenotypes involved in drug abuse
such as preference for particular drug classes (Comings et al., 1999), but not general
drug abuse. Additionally, failure to account for factors such as population admixture and
comorbidities could contribute to the discrepancies observed in human studies.

Mouse studies

Similar to early association studies in humans, early experiments in mice were based on
a priori assumptions about the role and importance of specific genes in drug abuse such
as the monoamine systems. The goal of early transgenic mouse models was to
investigate the consequences of direct manipulation of candidate genes and their
subsequent effects on behavioral and physiological drug abuse traits. To do this for
cocaine and methamphetamine exposure, many studies utilized knock-out (KO) mice
where a particular gene, coding for a component of the dopamine reward pathway (Giros
et al., 1996; Sora et al., 1998; Rocha et al., 1998) or the vesicular monoamine
transporter (Wang et al., 1997; Fukushima et al., 2007), was knocked out and a battery
of tests were run to quantify their effects. Most of these knockout strains were viable as
homozygotes; the exception is VMAT, which is homozygous lethal (Fon et al., 1997;
Wang et al., 1997).
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Dopamine transporter (DAT) KO mice showed increased activity in novel environments
(Giros et al., 1996; Sora et al., 1998; Zhuang et al., 2001), but no further increase in
activity following cocaine administration (Giros et al., 1996; Sora et al., 1998, 2001). This
suggested that DAT is important for development of drug abuse traits. However, further
studies that investigated behavioral effects focused on drug reward and drug
conditioning using conditioned place preference (CPP) and cocaine self-administration
demonstrated that DAT is not necessary. DAT knock-out mice in these studies showed
an intact CPP for cocaine and would self-administer drug at high dose indicating the
DAT is not necessary for cocaine reward (Sora et al., 1998; Rocha et al., 1998). Given
these findings, the field turned to the other monoamine systems that are affected by
psychostimulants including serotonin and norepinephrine transporters. These studies
produced similar results in KO mice of the serotonin transporter (SERT) (Sora et al.,
1998) and the norepinephrine transporter (NET) (Xu et al., 2000), where cocaine CPP
was maintained. However, Sora et al. highlight conflicting results amongst the literature
for CPP and self-administration in KO DAT, SERT, and NET mice (Sora et al., 2010).
Some studies report CPP and self-administration are unaffected following cocaine
exposure, while others show a decrease or increase. Similar results were obtained after
knockout of various dopamine receptors. For example, when the D3 receptor was
knocked out, mice showed increased locomotion in one study (Xu et al., 1997) but
decreased locomotion in another (Carta et al., 2000) after cocaine exposure.
Collectively, these results indicate that the effects of cocaine are not modulated through
a single system, but instead through many interacting systems with the potential for
compensatory components.
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Studies investigating the effects of methamphetamine on KO mice focused on the
monoamine transporters and the VMAT2 gene because one of the primary actions of
methamphetamine that differentiates it from cocaine is its action on neurotransmitter
release through the vesicular transporter. VMAT2 is present in dopaminergic,
noradrenergic, serotonergic, histaminergic, and trace aminergic neurons. Its presence in
so many aminergic systems explains why homozygous knockout of VMAT2, and
subsequently abolishment of monoaminergic neurotransmission, leads to lethality by two
weeks of age, as mice possess low monoamine levels in the brain despite increased
synthesis rates (Fon et al., 1997; Wang et al., 1997). Thus, heterozygous KO for VMAT2
were created instead for use in behavioral studies. Heterozygous VMAT2 deletion mice
show a decrease in presynaptic stores of neurotransmitters (Wang et al., 1997). Despite
this decrease in stores, these mice show increased locomotor response and
sensitization after methamphetamine exposure (Fukushima et al., 2007). This same
study revealed that heterozygous DAT KO mice show a decrease in locomotor activity
and sensitization following methamphetamine administration, but no interacting effects in
VMAT2/DAT double heterozygous mutants (Fukushima et al., 2007). Heterozygous
mutants may model a similar reduction in gene expression that can occur naturally in
humans, so to see effects on behavioral responses in these mutants provides further
evidence that variation in these genes may play a role in drug abuse traits.

The goal of many KO mice models was to determine or confirm the site of action of
cocaine and methamphetamine by eliminating the targets such as the monoamine
transporters through homozygous knockouts. However, these do not serve well as
models for human genetic variation because it is unlikely that homozygous deletions of
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these components exist naturally in human populations. In the case of heterozygous
knockouts such as with VMAT or DAT, the effects observed are closer to modeling the
natural genetic differences that may exist in humans. Even so, drug abuse traits are
highly polygenic and the use of single or double heterozygous mutants may not produce
an effect that is large enough to be detected. Many of these knockout studies contain a
narrow focus, looking strictly at the monoaminergic systems that have been shown to
play a large role in the molecular mechanisms underlying cocaine and
methamphetamine use. However, these studies do not allow for discoveries from a
broader view, uncovering unidentified, evolutionarily conserved neurogenetic
underpinnings of the effects of psychostimulants.

Genome-wide association studies

Complex disorders such as drug abuse are influenced by many genes, most of which
likely have a small effect on drug abuse phenotypes. For such complex phenotypes,
genome-wide association (GWA) approaches are likely to yield positive results. As
genetic sequencing became more prevalent and sophisticated, the drug abuse field
utilized sequencing technologies to interrogate multiple loci in the genome at once.
Given the unlikely nature of knockouts persisting naturally in human populations,
researchers sought to find allelic variants that exist in natural populations and are
associated with substance abuse using genome-wide association studies (GWAS). The
shift to genome-wide analyses began in the late 1990’s when researchers began a
series of GWAS examining drug dependence. Early studies utilized a small number of
single nucleotide polymorphisms (SNPs) and could only identify regions of
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chromosomes as opposed to specific genes (Uhl et al., 2001). Over time, as sequencing
technologies developed, the number of SNPs tested increased from 1500 (Uhl et al.,
2001) up to over 1 million (Drgon et al., 2010) by 2010. As the number of interrogated
SNPs increases, so too does the penalty associated with performing multiple
comparisons as is done in GWAS. When considering the trade-off between falsepositive and false-negative results, many GWAS used an arbitrary approach that
considered any SNP with a p-value <108 to achieve “genome-wide significance”. This
approach attempts to reduce false positives but is so stringent that it inflates the number
of false negatives. As a result, many studies were unable to identify any significant
genes. Given the stringency of these statistical parameters, some studies took alternate
approaches to identify genes of interest. One approach was to seek clustering of
nominally-positive results within separate samples and identify overlapping results
between the samples (Uhl et al., 2008a; Drgon et al., 2010) while another study looked
for convergence and overlap across multiple studies (Uhl et al., 2008b). These studies
all report enrichment for classes of genes involved in processes like cell adhesion and
transcription regulation. One important observation is the lack of genes from the
monoaminergic systems that were previously focused on in candidate gene studies.
These results highlight the potential role genes outside the monoaminergic systems may
play in drug abuse. Particularly, cell adhesion mechanisms are critical for establishing
and regulating connections during development and play a major role in synaptic
plasticity during memory formation (Benson et al., 2000; Welzl & Stork, 2003).

There are many challenges that exist when performing human GWAS, especially when
studying particular drugs of abuse. The small sample size of testable drug users
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exacerbates the problem of statistical power to detect significant genes. Heterogeneity in
different genetic backgrounds also reduces the statistical power to detect genetic
associations in complex traits (Manchia et al., 2013). Genotype-by-environment
interactions and epistatic interactions that can lead to failure to replicate main effects in
different populations with different allele frequencies of interacting genes (Mackay, 2014)
further complicate genetic studies in human populations. Humans commonly possess
many comorbidities such as polydrug use or psychiatric problems that confound the
results when studying single drugs such as cocaine or methamphetamine. To bypass
many of these issues, model organisms can be utilized to assess some of the genetic
underpinnings of cocaine and methamphetamine abuse.

Gene expression studies

In addition to identifying SNPs that contribute to abuse of cocaine and
methamphetamine, it is important to understand the downstream effects caused by
cocaine and methamphetamine. As mentioned previously, there has been extensive
research on the behavioral effects of cocaine and methamphetamine use, but the
underlying changes in gene expression that contribute to the effects of these drugs are
still poorly understood. In humans, gene expression studies have focused primarily on
few brain regions, using only post-mortem tissue (Zhou et al., 2011; Bannon et al., 2014;
Huggett and Stallings, 2019). The effects of cocaine and methamphetamine use likely
persist across the entire brain, however, this focus on few brain regions does not allow
for the detection of these brain-wide effects. Use of post-mortem tissue does not allow
for real-time detection of the effects of these drugs, but instead the effects after

14

overdose. These concerns are echoed in studies of other mammals including mice and
rats. These studies also focus on few brain regions previously implicated in reward
(Enoch et al., 2012; Zhu et al., 2015, 2016; Walker et al., 2018; Huggett and Stallings,
2019). To fully understand the underlying genetic and neuronal networks that
characterize the effects of cocaine and methamphetamine use, multiple brain regions or
the entire brain need to be investigated.

Fly studies

Complex traits like cocaine and methamphetamine abuse manifest their phenotypes
through the interplay of many genes with numerous environmental factors (Mackay et
al., 2009; Mackay, 2014). Thus, a comprehensive systems genetics analysis is
paramount in dissecting the underlying genomic architecture of cocaine and
methamphetamine abuse. In model systems, a systems genomic approach of cocaine
and methamphetamine abuse can be effectively executed because of the ability to
identify genetic and transcriptional networks that underlie the variation in effects of
cocaine and methamphetamine abuse. These networks can be validated using
environmental and genetic perturbations.

As mentioned previously, rodent models have provided many insights into the molecular
mechanisms underlying the effects of psychostimulant use by studying behavioral
effects of the drugs. However, these models experience challenges for forward genetic
approaches that look to identify genetic and transcriptional networks that contribute to
the effects of psychostimulant abuse. Primarily, the cost of animal maintenance and
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breeding, for a relatively small number of animals, is high. Also, the time required to
breed and maintain new animals is much longer than other organisms.

Drosophila melanogaster (Drosophila, “flies”) is a powerful model system that has been
used to study many complex traits and diseases and their underlying molecular, cellular,
developmental and genetic processes that are evolutionarily conserved throughout the
animal kingdom, including humans (Pandey & Nichols, 2011; O’Keefe & Denton, 2018;
Richardson & Portela, 2018). It has been estimated that 75% of human disease-causing
genes have orthologs in flies (Reiter et al., 2001; Pandey & Nichols, 2011). For genomic
studies, D. melanogaster presents many advantages. Large numbers of flies can be
reared and rigorously tested; the genetic background and environment can be controlled
precisely; flies have a short generation time and rapid life-cycle; the cost of rearing and
testing flies is more economical than mammalian models; for Drosophila there are many
publicly available genetic tools for studying the relationship between genes, the
environment, and phenotypes of interest.

Many behavioral effects of cocaine and methamphetamine use have been replicated in
Drosophila. When exposed to volatilized cocaine, flies show hyperactivity, continuous
grooming, body tremors, and akinesia (McClung and Hirsh, 1998; Torres and Horowitz,
1998; Bainton et al., 2000; Rothenfluh and Heberlein, 2002; Wolf and Heberlein, 2003;
Dimitrijevic et al., 2004; George et al., 2005). McClung and Hirsh also demonstrated that
repeated exposure of cocaine causes sensitization. Similar to its effects in humans,
methamphetamine causes arousal and suppresses food intake and sleep in flies
(Andretic et al., 2005; 2008; Walters et al., 2012). Flies also exhibit locomotor
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sensitization to methamphetamine after repeated exposures (Rigo et al., 2020). This
similarity in behavioral response and sensitization to cocaine and methamphetamine
between flies and rodents and humans suggests that the pathways leading to responses
and sensitization are evolutionarily conserved. Furthermore, high resolution x-ray
crystallography showed that cocaine and methamphetamine bind to the central binding
domain of the Drosophila melanogaster dopamine transporter (Wang et al., 2015).
Collectively, these data support the use of Drosophila as a model system to study the
underlying genomic responses induced by cocaine and methamphetamine.

The power and significance of genomics and Drosophila

One resource that has been created with Drosophila melanogaster for the purpose of
studying naturally occurring genetic variation on molecular and organismal phenotypes
at the genomic level is a panel of 205 wild-derived, inbred lines of flies known as the
Drosophila melanogaster Genetic Reference Panel (DGRP) (Mackay et al., 2012; Huang
et al., 2014). Each line within this panel is largely unrelated, fully sequenced, and well
annotated, with greater than 4.8 million SNPs identified across all lines. Additionally,
linkage disequilibrium decays rapidly with physical distance between SNPs (Mackay et
al., 2012). The DGRP is genetically variable for all traits assessed to date, including
alcohol sensitivity (Morozova et al., 2015; 2018), food consumption (Garlapow et al.,
2015), and response to drugs like methylphenidate (Rohde et al., 2019). Collectively,
this provides confidence in using the DGRP for studying the response to cocaine and
methamphetamine.
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GWAS

As with GWAS in other organisms, performing GWAS in the DGRP has some limitations
including the inability to evaluate associations with rare variants and a small sample size
that is restricted by the number of inbred lines (205). To overcome this, an outbred
advanced intercross population (AIP) derived from a subset of the 205 DGRP lines can
be constructed through a round robin crossing scheme (Huang et al., 2012). AIPs
consist of a population of a theoretically infinite number of unique genotypes while
maintaining the natural genetic variation that exists within the founder lines. Additionally,
linkage disequilibrium breaks down rapidly through successive generations of random
mating, allele frequencies of rare variants are increased in an AIP, and outbreeding
unmasks epistatic interaction, allowing for the detection of rare variants with large effects
that cannot be evaluated using GWAS of the original DGRP lines. One method for
achieving this is extreme QTL mapping (xQTL) (Ehrenreich et al., 2010; Huang et al.,
2012), where the entire allelic spectrum is surveyed and alleles that are differentially
segregated between the extremes of the phenotypic distribution are identified.
Comparing the top variants from GWAS from the DGRP and xQTL mapping previously
revealed the prevalence of epistatic interactions underpinning the genetic architecture of
quantitative traits (Huang et al., 2012; Shorter et al., 2015; Morozova et al., 2015;
Garlapow et al., 2017; Fochler et al., 2017), allowing novel genetic interaction networks
to be inferred. Utilizing GWAS in the DGRP and xQTL mapping in AIPs provides a
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unique ability to detect epistasis and construct interaction networks that display the
interplay of these genes on the effects caused by cocaine and methamphetamine use.

Gene expression

The small size of flies provides multiple advantages that bypass the drawbacks in gene
expression studies in mammals. The small size allows for the entire brain, head or body
to be collected from many flies and sequenced at a much-reduced cost compared to
mammalian counterparts. Sequencing the transcription profile of the entire brain, head or
body allows for detection of effects across these structures and co-expression networks
of differentially expressed genes can be constructed (Huang et al., 2015; Morozova et
al., 2018; Rohde et al., 2019).

The mammalian studies previously mentioned utilized “bulk” RNA sequencing, where all
cell types of a particular tissue, region or body part are processed and analyzed
together. However, cocaine and methamphetamine exhibit specific effects in different
regions of the brain and on different cell types within a specific brain region. These
effects may differ in direction and magnitude across different cell types or brain regions;
thus, opposite effects may prevent detection when cell types are analyzed together.
Single-cell and single-nucleus RNA sequencing help to disentangle this drawback by
sequencing the transcriptome of individual cells or nuclei within a sample (Tang et al.,
2009). There are few studies to date that have utilized these technologies to study the
effects of cocaine or methamphetamine. One study using rats performed single nucleus
RNA sequencing in the nucleus accumbens of rats following acute exposure to cocaine
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(Savell et al., 2020). In this study, an atlas of cell subtypes in the nucleus accumbens
was generated, and sex-specific and cell type-specific responses to cocaine were
identified in a small subset of medium spiny neurons. However, this study has the same
limitation mentioned previously for “bulk” RNA sequencing experiments: investigating
effects in only one brain region. These results give important insight into the role of
specific cell types in the nucleus accumbens, a region known to be important in
response to psychostimulants given the hallmark increase in dopamine in this brain
region following exposure. There are, however, other brain regions that likely play a role
as well that also need to be characterized.

Single-cell transcriptomics have previously been used in Drosophila to examine cellular
diversity in the midbrain (Croset et al., 2018) and across the entire aging adult fly brain
(Davie et al., 2018). These studies demonstrate the ability to utilize flies for single-cell
transcriptomics and provide a resource for identifying and mapping cell types across the
entire fly brain. An atlas of cell types in the brain has already been characterized, and
this information can be used as a template for further studies in the brain such as
monitoring cell-type specific expression changes following exposure to
psychostimulants. The use of flies for single cell transcriptomics studies is relatively costeffective due to their small size and the ability to sequence the transcriptomes of cells
from many entire brains in a single reaction.

Research purpose
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I have used D. melanogaster to identify and characterize the underlying genetic and
neurobiological factors that contribute to cocaine and methamphetamine use. I
specifically focused on identifying genetic variation and genetic interaction networks with
human orthologs that lead to increased use and preference for cocaine or
methamphetamine using GWAS in the DGRP and xQTL mapping in an advanced
intercross population. I performed brain single-cell RNA sequencing and constructed
genetic co-expression networks from these data. I also quantified behavioral effects with
the aim of correlating them with gene expression changes.

In summary, the research described herein addresses the following questions: What is
the underlying genetic architecture of increased cocaine and methamphetamine
consumption? What genetic variants contribute to differences in initial preference for
cocaine or methamphetamine and change in preference? What are the transcriptional
effects of acute exposure to cocaine in the fly brain? What specific cell populations
respond to cocaine exposure in the adult Drosophila brain? To what extent is there
sexual dimorphism in cocaine and methamphetamine response? We hypothesize that in
humans the genetic underpinnings of cocaine and methamphetamine use involve
processes beyond the monoamine systems and that other brain regions in addition to
the dopamine reward system play key roles in cocaine and methamphetamine response.
Lastly, we hypothesize that all cocaine and methamphetamine use traits are highly
sexually dimorphic.

In this thesis, chapter II encompasses an experiment that investigates the genetics of
cocaine and methamphetamine consumption and preference in a subset of inbred

21

Drosophila melanogaster lines. This experiment utilizes genome wide association
analyses and RNAi interference to identify and validate genes that contribute to
consumption and preference phenotypes. Chapter III will discuss an experiment that
investigates natural variation associated with increased consumption of cocaine and
methamphetamine in an advanced intercross population. This advanced intercross
population design will be leveraged to validate SNPs associated with increased
consumption. In chapter IV, I will present an experiment investigating the transcriptional
effects of acute cocaine exposure at single-cell resolution using 10x Genomics singlecell RNA sequencing platform. This will highlight cell-type specific changes that occur in
the brains of male and female flies exposed to cocaine.
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Introduction

Illicit use of cocaine and methamphetamine constitutes a significant public health
problem that incurs great socioeconomic costs in the United States and worldwide [1–3].
Cocaine and the amphetamine class of drugs are potent central nervous system
stimulants that act by raising synaptic concentrations of biogenic amines. Cocaine
inhibits neurotransmitter reuptake at dopaminergic, serotonergic and noradrenergic
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synapses [4,5]. Amphetamine increases neurotransmission by promoting the release of
dopamine from presynaptic vesicles through its actions on the vesicular monoamine
transporter and subsequent reverse flux of dopamine via the dopamine transporter and
through the plasma membrane into the synaptic cleft [6,7].

Amphetamine and methamphetamine are used clinically to treat attention deficit
hyperactivity disorder and narcolepsy. Long term use of these compounds, however, can
lead to addiction, and ultimately death [8]. The addictive properties of these drugs are
mediated through the dopaminergic mesolimbic reward pathway, which projects from the
ventral tegmental area via the nucleus accumbens to prefrontal cortex [9]. Although most
studies on psychostimulants focus on addiction, addiction represents only one facet of
the diverse organismal effects that result from psychostimulant drug abuse. These drugs
exert a wide range of physiological and behavioral effects, including suppression of
appetite, which can result in malnutrition, and severe cardiovascular, respiratory and
renal disorders. Use of cocaine and amphetamine can also cause mental disorders,
including paranoia, anxiety, and psychosis [10,11].

Susceptibility to the effects of cocaine and methamphetamine is likely to vary among
individuals and be determined both by environmental and genetic factors. However,
there is limited information regarding the genetic basis of susceptibility to the effects of
these drugs in human populations [12]. Twin and adoption studies have focused
primarily on alcohol abuse and illicit drugs, such as cannabis, with heritability estimates
ranging from ~30–70% [13,14]. Most studies on psychostimulant addiction to date have
centered on candidate genes associated with neurotransmission in the mesolimbic
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projection [12], and many of these are inconclusive or contradictory. For example, some
studies reported that alleles of the dopamine D2 receptor were associated with
substance abuse [15–18], whereas others did not replicate this finding [19–24]. Similar
contradictory results have been obtained for association analyses between
polymorphisms in the dopamine transporter gene and cocaine-related phenotypes [24–
28]. These contradictory findings may be due in part to failure to account for multiple
testing or population structure [29]. However, genetic studies of substance abuse and
addiction in human populations are challenging due to diverse social conditions and
physical environments, confounding factors with comorbid conditions such as alcoholism
or psychiatric disorders, and difficulty to recruit large numbers of study subjects due to
criminalization.

Drosophila melanogaster is an excellent model for identifying genes that affect drug
consumption behaviors since both the genetic background and environment, including
exposure to drugs, can be controlled precisely. These results have translational potential
since 75% of disease-causing genes in humans have a fly ortholog [30]. High resolution
X-ray crystallography has shown that the D. melanogaster dopamine transporter has a
central conformationally pliable binding site that can accommodate cocaine,
methamphetamine and their closely related analogues [31]. Similar to its effects in
humans, methamphetamine suppresses sleep, causes arousal and suppresses food
intake in flies [32–34]. In addition, cocaine and amphetamine exert quantifiable
locomotor effects in flies [35–41]. Thus, despite profound differences between the
neuroanatomical organization of the fly and vertebrate brains, it is likely that behavioral
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and physiological effects of methamphetamine and cocaine are mediated, at least in
part, by analogous mechanisms.

Here, we used the inbred, sequenced lines of the D. melanogaster Genetic Reference
Panel (DGRP [42,43]) to investigate the genetic basis for variation in psychostimulant
drug consumption. We used a four-capillary Capillary Feeding (CAFE) assay [44–46] to
quantify voluntary consumption, preference and change of consumption and preference
over time for cocaine and methamphetamine. Since cocaine and methamphetamine
both target dopaminergic synaptic transmission, but through different mechanisms, we
asked to what extent genetic networks that underlie variation in consumption of cocaine
and methamphetamine incorporate the same or different genes. We also sought to
determine the extent of sexual dimorphism for naïve and experience-dependent
voluntary drug intake. In addition, we asked how much variation in voluntary drug
consumption exists among different DGRP lines and what fraction of that variation is
accounted for by genetic variation. We showed that there is naturally occur- ring genetic
variation for all drug consumption traits with strong sex-, drug- and exposure timespecific components. We performed genome wide association (GWA) analyses to
identify candidate genes associated with the drug consumption behaviors that could be
mapped to a genetic interaction network. We tested the effects of RNAi mediated
suppression of gene expression [47] on all consumption behaviors for 34 candidate
genes and found that all affected at least one behavior in at least one drug and sex.
Finally, we used RNAi to suppress gene expression in neurons, glia, the mushroom
bodies and dopaminergic neurons in a subset of genes and showed that innate
preference and the development of preference for psychostimulant drugs involves
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dopaminergic neurons and the mushroom bodies, neural elements associated with
experience-dependent modulation of behavior.

Results

Quantitative genetic analysis of drug consumption behaviors in the DGRP

We used a four-capillary CAFE assay [44–46] to enable flies to choose to consume
either sucrose or sucrose supplemented with 0.2 mg/ml cocaine (or 0.5 mg/ml
methamphetamine), analogous to the two-bottle choice assay used in rodent studies [48]
(Fig 2.1). We quantified consumption for three consecutive days for males and females
from each of 46 DGRP lines that were unrelated, free of chromosomal inversions, and
free of infection with the endosymbiont Wolbachia pipientis [43; S2.1 Table]. These data
enabled us to assess whether there is naturally occurring genetic variation in this
population for naïve consumption of each solution and preference, and change of
consumption and preference upon repeated exposures (i.e., experience-dependent
modification of behavior).
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Fig 2.1. Consumption and preference assay. (A) Cartoon illustrating the four
capillary CAFE assay. Each of the three exposures consists of an 18 hour
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feeding trial with sucrose or drug + sucrose, followed by 6 hours recovery with
standard culture medium. (B) Positions of capillaries with the two solutions
(indicated by red and yellow).

We performed four-way mixed model analyses of variance (ANOVA) to partition variation
in consumption between DGRP lines, males and females, drug vs. sucrose, and the
three expo- sures. All main effects were significant for both drugs (Table 2.1), indicating
genetic variation for consumption, difference between amount of sucrose and drug
consumed, sexual dimorphism, and experience-dependent modulation of behavior. We
are most interested in the two- and three-way interaction terms involving Line, as they
indicate genetic variation in sexual dimorphism (L×X), change of consumption between
exposures (L×E), preference for sucrose or drug solution (L×S), and change of
preference for sucrose or drug between exposures (L×E×S). With the exception of L×S,
these interaction terms were significant for both the cocaine and methamphetamine
analyses (Table 2.1).
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Table 2.1. Analyses of variance of consumption measured over three
exposures. Exposure, Sex, Solution, and their interaction are fixed effects, the
rest are random. E: Exposure; X: Sex; S: Solution; L: DGRP Line; ε: residual; df:
degrees of freedom; MS: Type III mean squares; F: F-ratio test; P: P-value; σ2:
variance component estimate; SE: standard error; H2: Broad sense heritability.
Significant P-values are highlighted in bold font.
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We next performed reduced ANOVA models to quantify broad sense heritabilities (H2)
for consumption and change in consumption traits (S2.2 Table). We found significant
genetic variation in consumption of both drugs and sucrose alone within each sex and
exposure, with H2 ranging between 0.20 and 0.38 for cocaine consumption and between
0.22 and 0.30 for meth- amphetamine consumption (Fig 2.2, S2.2 Table). Further, there
was significant genetic variation for the change in consumption of sucrose alone or drug
in both sexes between the third and first exposures, with H2 ranging between 0.14 and
0.18 for cocaine and between 0.17 and 0.22 for methamphetamine (Fig 2.2, S2.2 Table).
Thus, there is genetic variation for both consumption and experience-dependent
consumption of both drugs and sucrose alone in the DGRP.
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Fig 2.2. Variation in drug consumption among 46 DGRP lines. (A) Initial
exposure. Lines are from lowest to highest consumption in females. (B) Third
exposure. The line order is the same as in (A). (C) Change in consumption
between exposures 3 and 1. Positive values indicate increased drug
consumption in Exposure 3. The line order is the same as in (A). Pink denotes
females, blue indicates males, and purple is overlap of both sexes. Error bars are
± 1SD.

Finally, we defined preference in two ways: as the difference between amount of drug
and sucrose alone consumed (Preference A), and as this difference scaled by the total
amount of both solutions consumed (Preference B). Variation in Preference A is the
statistical interpretation of the line by solution interaction; Preference B is the metric
commonly used in rodent studies [48]. Preference values of 0 indicate equal
consumption of sucrose alone and sucrose containing drug; values > 0 represent
preference for the drug and values < 0 indicate drug avoidance. Both preference metrics
were significantly genetically variable for each sex and exposure for cocaine, with H2
ranging from 0.06–0.16; while for methamphetamine, both preference metrics were
significantly genetically variable in females for all exposures (H2 from 0.05–0.18) and for
males in the second and third exposures (H2 from 0.08–0.11) (S2.2 Table). For cocaine,
the difference in Preference A between exposures 3 and 1 was significant only in
females (H2 = 0.11) while the difference in Preference B was significant for females (H2
= 0.13) and males (H2 = 0.05). For methamphetamine, the difference in Preference A
was significant in males (H2 = 0.04) and the difference in Preference B was significant in
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females (H2 = 0.04) (S2.2 Table). Thus, there is genetic variation for both innate drug
preference and experience- dependent drug preference in the DGRP.

The heritabilities of consumption traits are low, as is typical for behavioral traits,
indicating that environmental factors, including previous experience, predominantly
contribute to the observed phenotypic variation. The advantage of performing multiple
replicate measurements of each DGRP line is that the broad sense heritabilities of line
means (S2.3 Table) used in the GWA analyses (see below) are much greater than
heritabilities based on individual vials (S2.2 Table).

We computed the genetic and phenotypic correlations between males and females for
the consumption behaviors, between exposures for consumption and preference, and
between solutions (S2.4 Table). Cross-sex genetic correlations for consumption tended
to decrease with the number of exposures for both cocaine and methamphetamine,
suggesting that the experience-dependent modification of consumption is sex-specific.
Consumption of drugs and sucrose is highly correlated across the three exposures
(albeit significantly different from unity), while the correlations of drug preference across
exposures are low to moderate for both cocaine and methamphetamine in both sexes.
Although the consumption of drugs and sucrose for cocaine and methamphetamine are
genetically and phenotypically correlated in both sexes, preference for the two drugs is
not significantly correlated. Finally, Preference A and Preference B within each exposure
are nearly perfectly correlated, as expected since the difference in consumption is in
both metrics.
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In summary, we found that there is extensive genetic variation in consumption and
preference as well as change in consumption and preference with repeated exposures
for both cocaine and methamphetamine across different genetic backgrounds, and that
genetic variation for these traits has significant sex- and drug-specific components.

Genome wide association analyses of drug consumption in the DGRP

Our quantitative genetic analyses of consumption in the DGRP indicate that there is
genetic variation for all traits assessed, and that the traits have a complex correlation
structure indicating partially common and partially distinct genetic bases. Therefore, we
performed GWA analyses for 12 traits (drug and sucrose consumption exposure 1, drug
and sucrose consumption exposure 3, change in drug and sucrose consumption,
Preference A exposure 1, Preference A exposure 3, Preference B exposure 1,
Preference B exposure 3, change in Preference A, and change in Preference B) for
cocaine and methamphetamine, separately for males and females. We performed
association tests for 1,891,456 DNA sequence variants present in the 46 DGRP lines
with minor allele frequencies greater than 0.05 [43].

At a lenient significance threshold of P < 5 x 10−5, we identified 1,441 polymorphisms in
or near (within 1 kb of the start and end of the gene body) 725 genes for all consumption
behaviors related to cocaine, and 1,413 polymorphisms in or near 774 genes for
methamphetamine exposure (S2.5 Table). The majority of these variants had sexspecific effects. A total of 40 variants and 141 genes overlapped between cocaine and
methamphetamine. The variants in or near genes implicate candidate genes affecting
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consumption behaviors, while the intergenic variants could potentially contain regulatory
motifs for transcription factor-binding sites or chromatin structure regulating these traits.
Only two variants are formally significant following a Bonferroni correction for multiple
tests (0.05/1,891,456 = P < 2.64 × 10−8). 2L_10179155_SNP is located within an
intronic region in CG44153 and affects experience-dependent development of
methamphetamine preference in both sexes. Its human homolog ADGRB3 encodes a Gprotein coupled receptor, which contributes to the formation and maintenance of
excitatory synapes [49] and has been implicated in GWA studies on human addiction
[50]. 3R_27215016_SNP is a synonymous SNP in the coding sequence of CG1607 and
affects naïve consumption of sucrose. CG1607 encodes an amino acid transmembrane
transporter. One of its human ortho- logs, SLC7A5, is an amino acid transporter,
mutations in which are associated with autism spectrum disorder and defects in motor
coordination [51].

While not formally significant, we identified genes previously associated with cocainerelated behaviors (Bx [Lmo], loco, Tao) and ethanol-related behaviors (Bx, DopR, Egfr,
hppy, Tao, Tbh) [52] in D. melanogaster. In addition, the genes implicated by the GWA
analyses are enriched for multiple gene ontology (GO) categories and pathways [53,54]
at a false discovery rate < 0.05 (S2.5 Table). GO terms involved in nervous system
development and function were among the most highly enriched, consistent with the
known neurobiological mechanisms of action of these drugs. Finally, we note that ~ 70%
of the candidate genes from the GWA analyses have human orthologs, and many of
these genes have previously been associated with cocaine or methamphetamine abuse
in humans or with behaviors associated with intake and response to various
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psychoactive substances (alcohol, cannabis, nicotine, opioids) in humans as well as
zebrafish, mouse and rat models (S2.6 Table). This suggests that cocaine and
methamphetamine exert their effects in flies and humans through evolutionarily
conserved neural mechanisms.

These results suggest a highly polygenic architecture for variation in consumption and
drug preference, and that the genetic underpinnings for variation in consumption or
preference are both shared and distinct for cocaine and methamphetamine, consistent
with the quantitative genetic analyses.

A genetic interaction network for consumption behaviors

We next asked whether the genes we identified in the GWA analyses belonged to a
known genetic interaction network. Since the consumption behaviors are highly intercorrelated, we queried whether all 1,358 candidate genes from the GWA analyses for
both cocaine and meth- amphetamine combined could be clustered into significant subnetworks based on curated genetic interactions in Drosophila. If we do not allow any
missing genes, we find a significant (P = 9.99 × 10−4) network of 81 candidate genes
(Fig 2.3, S2.7 Table), most of which (88.9%) are predicted to have human orthologs [55].
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Fig 2.3. Significant genetic interaction network of genes identified in the
GWA analyses for all cocaine and methamphetamine related traits
combined. Borders indicate the strength of the evidence for a human ortholog.
Black: DIOPT score < 3; Blue: DIOPT score 3–6; Green: DIOPT score 7–9;
Orange: DIOPT score 10–12; Red: DIOPT score 13–15. See S2.7 Table for the
complete list of human orthologs and their DIOPT scores. Grey boxes have
effects on at least one drug-seeking behavior from RNAi knockdown of gene
expression.
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We performed enrichment analyses [53,54] to gain insight in the biological context for
genes in the network using a false discovery rate < 0.05. Surprisingly, many canonical
signal- ing pathways are highly enriched, including the Wingless (Wnt), Cadherin,
Cholecystokinin Receptor (CCKR), Transforming Growth factor beta (TGF), and
Fibroblast Growth Factor (FGF) signaling pathways. Concomitantly, we find high
enrichment of molecular function GO terms associated with regulation of transcription
and DNA and protein binding, and biological function GO terms associated with
development (including the development of the nervous system; S2.7 Table). These
results suggest that naturally occurring genetic variation in nervous system development
is associated with variation in propensity to consume psychostimulant drugs.
Furthermore, our results indicate that natural variants in key genes regulating all aspects
of fly development and function can be associated with variation in drug consumption
behaviors.

Functional evaluation of candidate genes

We used RNA interference (RNAi) to functionally test whether reduced expression of
candidate genes implicated by the GWA analyses affect consumption phenotypes. We
selected 34 candidate genes for RNAi mediated suppression of gene expression from
the set of GWA analyses (S2.5 Table). A total of nine of the candidate genes were in the
network; the others were chosen based on gene expression in the nervous system and
their known role in nervous system function, as well as belonging to enriched pathways
and gene ontology categories. We measured consumption of cocaine and sucrose (S2.8
Table) and methamphetamine and sucrose (S2.9 Table) for three consecutive days,
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separately for males and females, for each of the RNAi and control genotypes, exactly
as described for the DGRP lines.

We performed three-way fixed effect ANOVAs for each UAS-RNAi and control genotype,
separately for males and females (S2.10 and S2.11 Tables). The main effects in these
models are genotype (L, RNAi and control), solution (S, sucrose and drug) and exposure
(E, first and third). A significant L effect denotes a difference in overall consumption
between the RNAi and control genotypes; a significant S effect indicates a difference in
preference between sucrose alone and sucrose with drug; and a significant E effect
indicates a difference in consumption between exposures 1 and 3. Significant L×S and
L×E interaction terms denote, respectively, a difference in preference between the RNAi
and control genotypes, and a difference in consumption between exposures 1 and 3
between the two genotypes. A significant L×S×E interaction indicates a change in
preference with repeated exposure between the RNAi and control genotypes. We are
most interested in the main effect of genotype and interactions with genotype; i.e.,
consumption, preference, change of consumption and change of preference.

First, we used a weak ubiquitous GAL4 driver crossed to all 34 UAS-RNAi genotypes
and their respective controls. All candidate genes had a significant (P < 0.05) effect on at
least one of the consumption traits in at least one drug or sex combination. A total of 22
(25) genes affected consumption of cocaine (methamphetamine), 21 (23) affected a
change of consumption with exposure to cocaine (methamphetamine), 16 (10) affected
cocaine (methamphetamine) preference, and 11 (11) affected a change in cocaine
(methamphetamine) preference with exposure in males and/or females (S2.10 and
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S2.11 Tables, S2.1–S2.3 Figs). There were pronounced sex- and drug-specific effects
for all drug-related traits. The majority of RNAi genotypes showed reduced consumption
of cocaine and/or methamphetamine compared to their controls, dependent on exposure
and sex. If consumption is positively associated with gene expression, this suggests that
the products of these genes contribute to drug consumption. On the other hand, several
RNAi constructs caused increased drug consumption, suggesting that naturally
occurring variants that decrease expression of these genes could predispose to drug
preference. Finally, several RNAi-targeted genes exhibit a relative increase or decrease
in drug consumption compared to the control at the third exposure, indicating
experience-dependent change in preference.

To extend and refine our RNAi analysis, we next selected 10 genes (Dop1R1, Ect4, ed,
mld, msi, Oct-TyrR, olf413, Snoo, Vha100-1, wmd) from among those that showed
phenotypic effects when targeted by RNAi under the ubiquitous driver and which have
known effects on the nervous system. We assessed functional effects of these genes on
consumption traits when their corresponding RNAi constructs were expressed under the
control of the neuronal-specific elav driver or glial-specific repo driver. All of these genes
had a significant (P < 0.05) effect on at least one of the consumption traits in at least one
drug or sex combination under the elav driver, and all but Snoo had significant effects on
at least one of the consumption traits in at least one drug or sex combination under the
repo driver. With neuronal-specific suppression of gene expression, 9 (10) genes
affected consumption of cocaine (methamphetamine), 6 (7) affected a change in
consumption with exposure to cocaine (methamphetamine), 2 (7) affected cocaine
(methamphetamine) preference, and 3 (6) affected a change in cocaine
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(methamphetamine) preference with exposure in males and/or females (S2.10 and
S2.11 Tables, Fig 2.4, S2.4 Fig). With glia-specific suppression of gene expression, 4 (7)
genes affected consumption of cocaine (methamphetamine), 7 (6) affected a change in
consumption with exposure to cocaine (meth- amphetamine), 3 (0) affected cocaine
(methamphetamine) preference, and 2 (3) affected a change in cocaine
(methamphetamine) preference with exposure in males and/or females (S2.10 and
S2.11 Tables, Figs 2.4 and 2.5, S2.4 Fig). These effects were largely sex-, drug- and
driver-specific. We infer from these results that variation in gene expression in both
neurons and glia contributes to phenotypic variation in drug intake behaviors.
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Fig 2.4. Differences in cocaine preference and change in cocaine
preference between the third and first exposures between RNAi and control
genotypes. (A) Female Preference A. (B) Male Preference A. (C) Female
change of Preference A. (D) Male change of Preference A. Red, black, blue, and
green bars denote elav-GAL4, repo- GAL4, 201Y-GAL4 and TH-GAL4 drivers,
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respectively. Asterisks represent significant L×S terms (A, B) or significant
L×S×E terms from the full ANOVA models. Exact P-values are given in S2.10
Table.

Fig 2.5. Differences in methamphetamine preference and change in
methamphetamine preference between the third and first exposures
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between RNAi and control genotypes. (A) Female Preference A. (B) Male
Preference A. (C) Female change of Preference A. (D) Male change of
Preference A. Red, black, blue, and green bars denote elav-GAL4, repo-GAL4,
201Y-GAL4 and TH-GAL4 drivers, respectively. Asterisks represent significant
L×S terms (A, B) or significant L×S×E terms from the full ANOVA models. Exact
P-values are given in S2.11 Table.

In humans, the mesolimbic dopaminergic projection plays a role in drug addiction. In
Drosophila, the mushroom bodies could play an analogous role, as they are integrative
centers in the fly brain associated with experience-dependent learning [56,57],
dependent on dopaminergic input. To test whether the mushroom bodies and
dopaminergic projection neurons could serve as neural substrates that contribute to
variation in drug consumption or preference, we focused on four genes (Dop1R1, ed,
msi, Snoo,) that showed robust phenotypic effects when targeted with a corresponding
elav-driven RNAi. Knockdown of all four genes with a mushroom body specific driver
resulted in significant effects on consumption of cocaine and/or methamphetamine for at
least one drug and sex combination (S2.10 and S2.11 Tables, Figs 2.4 and 2.5, S2.5
Fig). Expression of RNAi in mushroom bodies affected change in consumption of
cocaine and methamphetamine for Dop1R1; cocaine preference and change of
methamphetamine preference for ed; change in consumption of cocaine for msi; and
cocaine and methamphetamine preference, cocaine preference, change of cocaine
preference and change of consumption of methamphetamine for Snoo. Expression of
RNAi in dopaminergic neurons affected change of consumption of cocaine and change
in methamphetamine preference for Dop1R1; consumption for cocaine and
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methamphetamine, change of consumption of methamphetamine and cocaine
preference for ed; consumption of cocaine and methamphetamine, change of
consumption of cocaine, and cocaine preference for msi; and all four traits for Snoo
(S2.10 and S2.11 Tables, Figs 2.4 and 2.5, S2.5 Fig). These effects are largely sex-,
drug- and driver-specific.

These results suggest that, despite differences in the genetic underpinnings of
susceptibility to cocaine and methamphetamine, phenotypic manifestation of genetic
variation in consumption and development of preference for both drugs is channeled in
part through a neural net- work that comprises dopaminergic projections to the
mushroom bodies.

Discussion

Although studies using mice [58,59], rats [60,61], primates [62] and humans [63] provide
important information about the cellular, developmental, physiological, and behavioral
effects of psychostimulants, these systems are less suited to dissecting the relationship
between naturally occurring genetic variation and phenotypic variation in individual
susceptibility to drug consumption and/or preference. Here, we show that D.
melanogaster harbors substantial naturally occurring variation for all consumptionrelated behaviors, including experience-dependent change in consumption, innate drug
preference and experience-dependent change in preference, under conditions where we
can obtain replicated measurements of consumption for each genotype in a choice
assay performed over three successive days under controlled environmental conditions.
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We show that genetic variation for consumption and preference metrics is both shared
between males and females and the different exposures, but is also sex-, exposure- and
drug-specific. Sex differences in drug self-administration and addiction have also been
shown in humans and mammalian animal models [64–72].

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) defines
11 criteria for substance use disorder in humans, all related to continuing to use of the
sub- stance despite adverse social and physiological effects and the development of
tolerance with repeated exposure. The DSM-V also recognizes that there is individual
variability of unknown etiology for the propensity both to experiment with
psychostimulants and to develop symptoms of substance abuse following initial
exposure. Previous studies of effects of cocaine [35,37–39,73–76] and
methamphetamine [77] in Drosophila examined mutations and pharmacological
interventions using locomotor-based assays, clearly demonstrating an adverse effect of
these substances. However, previous Drosophila studies have not assessed naturally
occurring variation in drug self-administration and change in this behavior on repeated
expo- sure, which may better model the genetic basis of individual susceptibility–or
resistance–to substance abuse and the development of tolerance (increased drug
preference over time).

To begin to understand the nature of the genetic basis for variation in drug consumption
and preference, we performed GWA analyses for all consumption traits, separately for
cocaine and methamphetamine, using 1,891,456 DNA sequence variants present in the
46 DGRP lines with minor allele frequencies greater than 0.05 [43]. We identified 1,358
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unique candidate genes using a lenient significance threshold of P < 5 x 10−5. We
hypothesized that these candidate genes would be enriched for true positive
associations despite the low power of the GWA analyses and that choosing genes for
functional evaluation from this list would be more productive than choosing genes at
random. Observations supporting this hypothesis are that mutations in several candidate
genes have previously been shown to affect cocaine or ethanol- related phenotypes in
Drosophila [52], that the candidate genes are highly enriched for GO terms involved in
the development and function of the nervous system, and that 81 candidate genes can
be assembled into a known genetic interaction network (Fig 2.3), which is highly unlikely
(P = 9.9 x 10−3) to occur by chance. The candidate genes in the significant genetic
interaction network are enriched for several canonical signaling pathways as well as all
aspects of development, including nervous system development. These observations
suggest that sub- tle genetic variation in nervous system development is associated with
variation in propensity for consumption of psychostimulant drugs. Nearly 90% of the
genes in the network have human orthologs and are candidates for future translational
studies.

We selected nine candidate genes in the significant genetic network and 25 additional
candidate genes to assess whether RNAi reduction using a weak ubiquitous GAL4 driver
affected consumption traits, using the same experimental design as for the DGRP lines.
All of these genes affected at least one consumption trait/sex/drug. However, there is
considerable variation in the effects of different drivers on consumption, preference and
change in preference for cocaine and methamphetamine, which likely reflects variation
in the effects of RNA interference on different neural elements of a complex integrated
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neural circuitry. Indeed, several candidate genes, functionally implicated by RNAi, are
associated with neural development and represent several early developmental
signaling pathways. Snoo has been identified as a negative regulator of the
decapentaplegic signaling pathway [78,79] and has been implicated in dendritic
patterning [80]. Echinoid, the gene product of ed, is an immunoglobulin domain
containing membrane protein of adherens junctions that interacts with multiple
developmental signaling pathways, including Egfr, Notch and Hippo signaling [81–83].
Musashi, encoded by msi, is a neural RNA binding protein that interacts with Notch
signaling to determine cell fate [84]. RNAi targeting of expression of these genes under
MB-GAL4 or TH-GAL4 drivers show different effects on consumption, change in
consumption, preference and change in preference for the two drugs (S2.5 Fig).

Among the functionally validated candidate genes, Oct-TyrR and Dop1R1 are of special
interest. Oct-TyrR encodes an octopamine-tyramine receptor expressed in mushroom
bodies [85], and Dop1R1, which encodes a dopamine receptor enriched in the
mushroom bodies, has previously been implicated in aversive and appetitive
conditioning [86], innate courtship behavior [87] and sleep-wake arousal [88]. Loss-offunction mutations of Dop1R1 increase sleep and these effects are reversed by
administration of cocaine [88]. Octopamine and tyramine act on astrocytes via the OctTyr1 receptor and this activation of astrocytes can in turn modulate dopaminergic
neurons [89]. Thus, we can hypothesize that combinations of octopaminergic and
dopaminergic signaling in the mushroom bodies can modulate drug consumption and/or
experience-dependent changes in consumption or preference following repeated
exposure to cocaine or methamphetamine.
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Finally, genes which were functionally validated with RNAi represent evolutionarily conserved processes. Future studies can assess whether their human counterparts play a
role in variation in susceptibility to psychostimulant drug use in human populations.

Materials and methods

Drosophila stocks

The DGRP, UAS-RNAi and GAL4 driver lines used are listed in S2.12 Table. The DGRP
lines are maintained in the Mackay laboratory. RNAi lines [47] were obtained from the
Vienna Drosophila Resource Center and the GAL4 driver lines from the Bloomington,
Indiana Drosophila stock center. All lines were maintained on standard
cornmeal/yeast/molasses medium at 25 ̊C on a 12 hour light/dark cycle with constant
humidity of 50%.

Consumption assay

We used a four-capillary Capillary Feeder (CAFE) assay [44–46] to measure drug
consumption. Briefly, five 3–5 day old flies per genotype/sex were anesthetized using
CO2 and placed on cornmeal/yeast/molasses/agar medium one day prior to the assay.
Flies were transferred without anesthesia 45 minutes prior to the assay to vials
containing 4-5ml of 1.5% agar (Sigma Aldrich). Two capillaries (VWR International: 12.7
cm long, 5 μl total volume) containing 4% sucrose (Sigma Aldrich) + 1% yeast (Fisher
Scientific) or 4% sucrose + 1% yeast + drug, with a mineral oil (Sigma Aldrich) overlay
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(to minimize evaporation), were inserted in the top of each vial. Cocaine and
methamphetamine were obtained from the National Institute on Drug Abuse under Drug
Enforcement Administration license RA0443159. Flies were allowed to feed for 16–18
hours with the vials placed in an enclosed plastic chamber wrapped in a plastic bag
under a 12 hour light/dark cycle with constant humidity of 50%. For each experiment, an
identical set of vials without flies was included in each chamber to determine evaporation
loss. The capillaries were then removed and the volume of food consumed (1 mm =
0.067 μl) in each calculated as described previously [90]. The capillaries were replaced
with a Drosophila activity monitor (DAM) tube (TriKinetics, Inc. Waltham, MA) containing
standard cornmeal/ yeast/molasses medium for a recovery period of 4–6 hours. The
assay was performed on three consecutive days for each vial of flies. The order in which
the assays were performed was pre- served throughout the three exposures: the first vial
replicate to enter the consumption assay was the first to be allowed to recover for each
of the three exposures; and the last vial replicate to enter the consumption assay was
the last to be allowed to recover for each of the three expo- sures. In this way flies in all
vials were exposed to the same duration of feeding and recovery. A total of 10 replicate
vials were tested for each genotype and sex.

We defined four behaviors: total amount of each solution consumed, drug preference,
and change in consumption and change of preference between exposures 3 and 1.
Preference was quantified in two ways: as the difference between the amount of drug
and sucrose consumed (Preference A), and as this difference scaled by the total amount
consumed (Preference B).
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Genetic variation in drug consumption behaviors in the DGRP

We performed four-way factorial mixed model analyses of variance (ANOVA) to partition
variation in consumption in the DGRP: Y = μ + L + E + S + X + (L × E) + (L × S) + (L × X)
+ (E × S) + (E × X) + (S × X) + (L × E × S) + (L × E × X) + (L × S × X) + (E × S × X) + (L
× E × S × X) + ε, where Y is consumption; μ is the overall mean; L is the random effect
of line; E, S, and X are the fixed effects of exposure (day 1–3), solution (drug, sucrose),
and sex (males, females); and ε is the residual variation between replicate vials. The
main effect of L and all interaction terms with L are genetic factors affecting drug
consumption. We also ran the same ANOVA models to compare the effects of cocaine
and methamphetamine on consumption, separately for males and females. The full
model for variation in change in consumption over time is Y = μ + L + S + X + (L × S) +
(L × X) + (S × X) + (L × S × X) + ε. We assessed variation in the development of
preference using the model Y = μ + L + E + X + (L × E) + (L × X) + (E × X) + (L × E × X)
+ ε. We also assessed whether there is natural variation in the change of preference
over time using the model Y = μ + L + X + (L × X) + ε. We also ran reduced models for
each trait. All ANOVAs were performed using the PROC GLM function in SAS. We used
the R function pf to assign exact P-values.

Quantitative genetic analyses in the DGRP

We used the SAS PROC MIXED function to estimate variance components for each of
the random effect terms in the full and reduced models. The R package lmer and
lmerTest were utilized in combination with the pchisq function to assign P-values for the
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segregating genetic variation for each trait. We computed broad sense heritabilities as
the sum of all genetic variance components divided by the total phenotypic variance for
each model, and broad sense heritabilities of line means as the sum of all genetic
variance components divided by the sum of all genetic variance components plus the
environmental variance/10, where 10 is the number of replicate vials per line, sex,
exposure and treatment. We computed pairwise genetic correlations as rG =σ2L/σL1σL2,
where σ2L is the among line variance from the appropriate two-way factorial ANOVA and
σL1 and σL2 are the among line standard deviations from the one-way ANOVA for each
condition. We computed Pearson product-moment correlations of line means to estimate
phenotypic correlations between different traits.

Genome wide association mapping in the DGRP

We performed GWA analyses on line means for all consumption traits using the DGRP
pipe- line (http://dgrp2.gnets.ncsu.edu/) [43]. This pipeline implements single-variant
tests of association for additive effects of variants with minor allele frequencies ≥ 0.05.
We tested effects of 1,891,456 DNA sequence variants on each trait.

Network analysis

We annotated candidate genes identified by the GWA analyses using Flybase release
5.57 [56] and mapped gene-gene networks through the genetic interaction database
downloaded from Flybase. We then constructed a subnetwork using Cytoscape 3.5.1
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where candidate genes directly interact with each other. We evaluated the significance
(α = 0.05) of the constructed subnetwork by a randomization test [91–93].

Gene ontology analysis

We carried out gene ontology (GO) enrichment analysis with PANTHER 11.1 (http://
pantherdb.org/) [53,54].

RNAi knockdown of gene expression

We used the binary GAL4-UAS system for RNAi-targeted knockdown of expression of
candidate genes associated with variation in consumption of cocaine or
methamphetamine with a weak ubiquitous driver (Ubi156-GAL4) and drivers specific for
neurons (elav-GAL4), glia (repo-GAL4), mushroom bodies (201Y-GAL4) and
dopaminergic neurons (TH-GAL4). We crossed 3 homozygous GAL4 driver males to 5–
7 homozygous females harboring a unique UAS-RNAi transgene or the progenitor
control to generate F1 GAL4-UAS-RNAi and GAL4 control progeny. We assessed the
consumption traits exactly as described above for the DGRP lines. Differences between
RNAi lines and their corresponding control lines for consumption were assessed with a
fixed-effect ANOVA, separately for males and females. The full model was: Y = μ + L +
E + S + (L × E) + (E × S) + (L × S) + (L × E × S) + ε, where Y denotes the mean
consumption, E denotes the different exposures, L is the line (Control or RNAi), S
denotes the different solutions (sucrose or cocaine/methamphetamine), and ε the error
variance. Differences between RNAi lines and controls for change in consumption and
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preference were also assessed with fixed-effect ANOVAs. The full model for change in
consumption was: Y = μ + L + S + (L × S) + ε, while the full model for preference was Y
= μ + L + E + (L × E) + ε. All ANOVAs were run using R.
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Introduction

The use of illicit drugs such as cocaine and methamphetamine contributes to greater
than 200,000 deaths worldwide, with an annual economic cost of over $740 billion in the
U.S. alone (1,2). The neurobiology and mode of action of cocaine and
methamphetamine is well known. Both drugs are psychostimulants that act on the
dopaminergic projection from the ventral tegmental area to the nucleus accumbens.
Cocaine blocks the reuptake of dopamine by binding to dopamine transporters on
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presynaptic neurons (3,4). Methamphetamine increases release of dopamine from
presynaptic vesicles by reversing the flow of vesicular monoamine transporters (5).

Cocaine and methamphetamine use lead to suppressed appetite resulting in
malnutrition, arousal, hyperactivity and, with chronic use, cardiovascular and respiratory
disorders (6-9). Susceptibility to substance use disorders varies among individuals in
human populations and is determined by both genetic and environmental factors.
However, our knowledge of the genetic basis of susceptibility to psychostimulants is
limited (10). Animal model studies have focused primarily on manipulating genes based
on a priori knowledge, focusing mainly on genes associated with neurotransmission in
the mesolimbic reward pathway (11-16). Although monoaminergic systems play a role in
the molecular mechanisms of response to psychostimulant intake, drug abuse
phenotypes are highly polygenic and encompass diverse physiological manifestations.
Human genome wide association (GWA) studies identified genes and allelic variants
associated with drug abuse phenotypes (17-19). However, such studies face challenges
and limitations due to the difficulty in recruiting subjects because of criminalization of
substance abuse, and hence relatively small samples sizes; variation in drug exposure;
heterogeneity in genetic backgrounds and environments; and comorbidity with other
neuropsychiatric disorders such as alcoholism.

Drosophila melanogaster presents a powerful genetic model since the genetic
background and environment can be precisely controlled, drug consumption can be
measured in large numbers of flies (20), and 75% of disease-causing genes in humans
have a fly ortholog (21). Cocaine and methamphetamine bind to the central binding site
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of the D. melanogaster dopamine transporter (dDAT) (22), and flies exhibit many of the
effects that are observed in humans upon cocaine and methamphetamine exposure,
such as increased arousal, suppressed sleep and decreased food intake (23,24).

The D. melanogaster Genetic Reference Panel (DGRP) is a collection of 205 fully
sequenced, inbred lines derived from a natural population (25,26). A GWA study that
measured consumption of cocaine and methamphetamine in a subset of the DGRP lines
revealed genetic variation for drug consumption (20). Furthermore, DGRP derivedoutbred populations can be constructed to circumvent limitations of the statistical power
inherent in the small sample size of the DGRP, as illustrated by a previous study on the
genetic basis of ethanol consumption (27).

Here, we utilize an advanced intercross population (AIP) derived from 37 DGRP lines
that are maximally homozygous, unrelated, and free of inversions or infection by the
symbiont Wolbachia pipientis, to dissect the genetic underpinnings for variation in
consumption of cocaine and methamphetamine. We report the use of allele-specific
AIPs as an experimental strategy that can validate causality of individual allelic variants
associated with variation in cocaine or methamphetamine consumption identified in
GWA studies.
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Results

Phenotypic variation in drug consumption

To determine the optimal concentration to assess variation in consumption of cocaine
and methamphetamine, we used the Capillary Feeder (CAFE) assay (27-30) (Fig. 3.1).
We quantified voluntary consumption of 4% sucrose and 4% sucrose supplemented with
0.05, 0.1, 0.2, 0.3, 1.0 and 3.0 µg/µL cocaine or methamphetamine for three- to five-dayold AIP flies (Table S3.1). Overall consumption decreased with increasing
concentrations of both drugs for both sexes, with a concentration of 1.0 µg/µL near the
inflection point of the sigmoidal distribution for both methamphetamine and cocaine (SI
Appendix, Fig. S3.1).
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Fig. 3.1. Capillary Feeder (CAFE) assay. Individual flies are collected and
placed in vials containing standard fly medium 24 hours prior to beginning the
experiment. Flies are then transferred to vials containing 1.5% agar medium,
plugged with a foam plug. A capillary filled with the appropriate treatment and a
mineral oil cap is then inserted through the foam plug. The initial liquid level is
marked on each capillary. Vials are placed in wire racks and the racks are placed
inside a plastic container. The plastic container is placed inside a large
transparent bag to create a humidified chamber. After 18 hours of feeding, the
final liquid levels are marked, and the differences between the initial and final
liquid levels are quantified.
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Using 1.0 µg/µL cocaine or methamphetamine, we evaluated voluntary consumption of
sucrose, sucrose plus cocaine and sucrose plus methamphetamine (hereafter
designated the sucrose, cocaine and methamphetamine treatments, respectively) in the
AIP. We phenotyped two replicates of 1,500 flies for each treatment and sex, for a total
of 18,000 individual flies (Table S3.1). There was substantial variation in consumption of
cocaine, methamphetamine, and sucrose in the AIP. The phenotypic distribution for
each condition and sex, however, was right skewed with most flies consuming little to no
solution, especially for cocaine (SI Appendix, Fig. S3.2). This large proportion of lowconsuming flies is likely due to a combination of factors: some flies may not learn to
drink from the capillaries; flies may have an aversive gustatory response to the drug
solutions; and flies may choose not to consume.

Gustatory aversion

To determine the impact gustatory aversion has on voluntary consumption of cocaine
and methamphetamine, we measured proboscis extension responses (PER) (31). Flies
extend their probosces in response to a palatable tastant, but not to an aversive tastant.
We quantified the PER for naïve AIP males and females in response to sucrose, 1.0
µg/µL cocaine and 1.0 µg/µL methamphetamine (100 flies per sex and treatment) (Table
S3.2). We found a significant decrease in the PER to both drugs in both sexes when
compared to sucrose (Chi-square P < 0.05, SI Appendix, Fig. S3.3A). However, the
gustatory aversion is not large enough to explain the proportion of flies that did not
consume cocaine or methamphetamine in the CAFE assay. Thus, natural variation in
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gustatory aversion to cocaine and methamphetamine may contribute in part to the
observed variation in voluntary consumption but is not likely to be the major contributing
factor.

Next, we assessed whether prior consumption of cocaine and methamphetamine affects
the propensity for PER. We assessed consumption of 1.0 µg/µL cocaine (240 females,
181 males) and 1.0 µg/µL methamphetamine (238 females, 211 males) for naïve AIP
flies, and then measured their PER (Table S3.2). For methamphetamine, in both sexes,
there was no significant difference in consumption between flies that extended their
probosces (“extenders”) and those that did not (“non-extenders”) (male P = 0.28; female
P = 0.72; SI Appendix, Fig. S3.3B). For cocaine, there was no significant difference in
consumption between extenders and non-extenders in males (P = 0.07; SI Appendix,
Fig. S3.3B). In females, extenders consumed less cocaine than non-extenders (P =
0.0051; SI Appendix, Fig. S3.3B), indicating consumption does not correlate with
propensity for PER.

Extreme QTL (xQTL) GWA analyses

To explore the genetic underpinnings of drug consumption, we performed whole genome
sequencing on the pools of high consumers and random flies to identify differentially
segregating alleles. We collected and pooled the top 10% of consumers for each
treatment, sex, and replicate (150 flies total per sex/condition), as well as 150 random
flies per treatment, sex, and replicate. We compared allele frequencies in the high
consuming pools with their respective controls and considered SNPs with a Bonferroni
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corrected P-value of P < 1.9 × 10-8 significant for each comparison (Table S3.3). In
females, we identified 152, 225, and 731 SNPs in or near 128, 169, and 563 genes with
significant differences in allele frequency between the high consuming and control pools
for the methamphetamine, cocaine and sucrose treatments, respectively (SI Appendix,
Fig. S3.4). In males, we identified 871, 60, and 999 SNPs in or near 700, 48, and 686
genes with significant differences in allele frequency between the high consuming and
control pools for the methamphetamine, cocaine and sucrose treatments, respectively
(SI Appendix, Fig. S3.4). Across all comparisons, we identified 3,033 SNPs with
significant differences in allele frequencies between high consuming and control pools,
mapping within 1 kb of 1,962 genes. We observe little overlap at the SNP level and a
greater amount of overlap at the gene level between the different sexes and treatments
(Fig. 3.2A). The majority of the overlap in genes involved sucrose consumption in either
females or males, which may be a result of common genetic determinants of general
food intake. Of the 988 genes identified in the drug conditions, 650 (65.6%) possess a
putative human ortholog (DIOPT ≥ 3) (Table S3.4).
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Fig. 3.2. Genes associated with methamphetamine and cocaine
consumption. (A) Numbers of genes with allele frequencies that are significantly
different between high consuming flies and random control flies. The dots on the
x-axis indicate the treatment(s) in which the candidate genes were detected. The
vertical lines indicate genes that were identified in more than one treatment. The
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horizontal bars indicate the number of significant genes for each treatment. (B)
Genetic network without missing genes constructed from a subset of candidate
genes identified in the xQTL mapping analysis at a Bonferroni corrected
significance level. The network consists of 77 interconnected genes (P < 0.001),
of which greater than 83% possess a human ortholog (oval nodes; DIOPT ≥ 3).
Blue nodes indicate genes associated with nervous system development or
function. (C) A genetic interaction network constructed from the human orthologs
of genes in (B). Rectangles represent the input human orthologs. Triangles
represent computationally recruited genes. Colored nodes indicate the gene is
involved in apoptosis (purple), epidermal growth factor receptor (EGFR) signaling
(blue), nerve growth factor (NGF) signaling (gray), vascular endothelial growth
factor (VEGF) signaling (green), integrin cell surface interactions (red), or
interactions of immunoglobin superfamily (IGSF) member proteins (yellow).

We performed gene ontology enrichment analysis using the PANTHER
Overrepresentation Test (32) and the GO Ontology database (33) for all significant
genes in both sexes and both drug treatments, for all significant genes in the cocaine or
methamphetamine treatments in both sexes, and for sexes and treatments separately.
These analyses reveal enrichment for processes involved in development and
morphogenesis, and in particular development and function of the nervous system
(Table S3.5).
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Genetic interaction networks

We asked whether genes identified in the xQTL analysis were known to interact in
previously curated genetic interaction networks. Without computationally recruiting
missing genes, we identified a significant (P = 0.001) network with 77 genes, 83.1% of
which contain human orthologs (DIOPT ≥ 3) (Fig. 3.2B). Enrichment analysis of this
network reveals enrichment of genes associated with elements of nervous system
development, including axon extension and guidance, apoptosis; and the Wnt, hippo,
Notch, and BMP signaling pathways (Table S3.6).

Using the human orthologs of the genes in the network mentioned above, we
constructed a human genetic interaction network by allowing interactions to be mediated
by genes not present in our list (Fig. 3.2C). This network is comprised of 66 genes, of
which 22 are orthologs of genes in the Drosophila genetic interaction network. Multiple
biological processes are represented in the network including apoptosis, epidermal
growth factor receptor (EGFR) signaling, nerve growth factor (NGF) signaling, vascular
endothelial growth factor (VEGF) signaling, integrin cell surface interactions, and
interactions of immunoglobin superfamily (IGSF) member proteins.

We also constructed a significant (P < 0.001) genetic interaction network in which we
integrated 197 genes from a DGRP GWA study on cocaine and methamphetamine
consumption (20) with the significant genes from the current study (SI Appendix, Fig.
S3.5). As expected, the genes in this network are enriched for associations with nervous
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system development, but there is also enrichment for genes involved in response to
cocaine (Table S3.7).

Functional assessment of candidate genes using RNA interference (RNAi)
We utilized RNA interference (RNAi) to test whether reduced expression of candidate
genes identified in the xQTL analysis affects consumption. We selected 22 candidate
genes based on the following criteria: they are among the top 10 significant genes (i.e.,
lowest P-values) per treatment or they overlap between at least two treatments; they
have a human ortholog with a DIOPT score ≥ 5; there are multiple significant SNPs in
the same candidate gene; the allele frequency differences between the control and high
consumption pools are in the same direction; the differences in allele frequencies
between the control and high consumption pools are consistent across replicates; and
an RNAi line with no off-target effects is available in the same genetic background from
the Vienna Drosophila Resource Center. For each RNAi line and its co-isogenic control,
we measured consumption of cocaine, methamphetamine, or sucrose for 40 males and
40 females for each genotype and treatment tested (Table S3.8). We only tested the
conditions for which a SNP was significant for at least one sex in the xQTL analysis.
Thus, we tested 18 RNAi lines for methamphetamine consumption, 8 lines for cocaine
consumption, and 12 lines for sucrose consumption using the fixed-effects ANOVA
model Y = µ + S + G + S×G + ε and the reduced model Y = µ + G + ε for sexes
separately, where Y is consumption, µ is the overall mean, S is sex (male or female), G
is genotype (control or RNAi) and ε is the error term.
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RNAi targeting of 17 genes had nominally significant G and/or S×G effects in the full
model ANOVAs for cocaine and methamphetamine consumption (ANOVA, P ≤0.05;
Table S3.9). Overall, we validated 77% of candidate genes with differential allele
frequencies in the AIP populations that are associated with differences in
psychostimulant consumption using RNAi knockdown. A total of 11 of these genes had
significant S×G effects, indicating genetic variation in sexual dimorphism, which can
occur if the effect of RNAi on drug consumption is significant in only one sex (sexspecific), if the effects are significant and in the same direction in both sexes but of
different magnitudes in males and females, or if there are opposite effects on drug
consumption in males and females (sex-antagonistic). Five of the genes (CG11619,
qless, Pvr, RagA-B, sim) had sex-antagonistic effects and two (CG9328, hoe1) had sexspecific effects on methamphetamine consumption; four additional genes (arr, Cip4,
Nipped-A, nito) had sex-specific effects on cocaine consumption. All other genes
affecting drug consumption were significant in only one sex, even though the S×G
effects were not significant (Fig. 3.3A, 3.3B). In accordance with the GWA analyses,
genetic variation in sexual dimorphism is a hallmark of cocaine and methamphetamine
consumption in Drosophila.
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Fig. 3.3. Differences in methamphetamine (A), cocaine (B), and sucrose (C)
consumption between RNAi and control genotypes for 22 candidate genes.
Data are presented as the difference between the amount consumed in the RNAi
line and the amount consumed in the control line. Deviations below zero indicate
less consumption in the RNAi line versus the control and deviations above zero
indicate greater consumption in the RNAi line. Blue bars denote males and red
bars denote females. Bars with an asterisk indicate a significant difference from
control (ANOVA, P < 0.05).

We tested consumption of both cocaine and methamphetamine for four of the 22
candidate genes (arr, Cip4, pum, and Mob2). Cocaine and methamphetamine
consumption are significantly different for all four genes (ANOVA treatment (T) term, P <
0.05; Table S3.9) and for all but Mob2, the genotypes respond differently to cocaine and
methamphetamine, as indicated by the significant G×T term. Similarly, we tested nine
genes for consumption of methamphetamine and sucrose and three genes for
consumption of cocaine and sucrose. Sucrose and drug consumption are significantly
different for all of these genes (ANOVA T term, P < 0.05; Fig. 3.3C, Table S3.9). Seven
genes showed genotype-specific differences in consumption of drugs and sucrose
(significant G×T or G×T×S terms), while five genes had similar effects of RNAi on drug
and sucrose consumption (Table S3.9). Similar to the GWA results, the effects of RNAi
of candidate genes on consumption is both shared and distinct between cocaine and
methamphetamine, and between drugs and sucrose.
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Functional assessment of candidate SNPs

Whereas RNA interference can corroborate GWA results associated with cocaine and
methamphetamine consumption at the level of genes, this method cannot be used to
functionally evaluate candidate variants. In addition, SNPs that are in intergenic regions
and have large phenotypic effects cannot be validated using publicly available RNAi
constructs. To circumvent these limitations, we designed a SNP validation assay by
taking advantage of the extensive annotation of variants in the DGRP. We constructed a
different set of allele-specific AIPs where alternative SNP alleles were made
homozygous in an otherwise randomized genetic background. To independently assess
the effects of individual SNPs on cocaine or methamphetamine consumption, we
constructed each allele-specific AIP by choosing 10 DGRP lines with the high
consumption allele (H) and 10 DGRP lines with the alternative control allele (C)
implicated by the xQTL GWA analysis for each SNP of interest. None of the DGRP lines
used to construct any of the allele-specific AIPs were the parental lines used to construct
the AIP for the xQTL GWA analyses. The 10 H allele DGRP lines and the 10 C allele
DGRP lines were separately crossed in a round-robin crossing scheme and maintained
for at least 35 generations of random mating in large populations before testing cocaine
and methamphetamine consumption in the C and H AIPs.

We constructed allele-specific AIPs for five intergenic SNPs and SNPs located within 1
kb of five annotated genes. We used the following criteria to select intergenic SNPs: they
are among the top 20 significant SNPs (i.e., lowest P-value) per treatment; their
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differences in allele frequencies between high consuming and control pools are
consistent across replicates; they are located in a transcription factor binding site, repeat
region, or known regulatory region; they are in a binding site for more than one
transcription factor; and there are at least 10 DGRP lines that contain the “H” or “C”
allele. We selected genic SNPs that are among the top 10 significant genes per
condition based on their P-value, or overlap between at least two treatments; they have
a human ortholog with a DIOPT score ≥ 5; if there are multiple SNPs, the allele
frequency differences between the high consumers and control pools are in the same
direction; the allele frequency differences between the high consumers and control pools
are consistent across replicates; they have an effect size greater than 2; the gene is in a
GO category associated with nervous system development and function; and there are
at least 10 DGRP lines that contain the H or C allele. These populations are designated
by an arbitrary SNP number (1-5) or gene name followed by a C or H to indicate
homozygosity for the H or C allele (e.g., qlessH and qlessC) (Table S3.10).

For each population, we measured consumption of cocaine and/or methamphetamine
for 150 males and 150 females (Table S3.11). We only tested populations for
consumption of the drug for which the SNP was significant in the original AIP xQTL
GWA analysis (SI Appendix, Fig. S3.6). Therefore, all populations except for SNP5 were
tested for methamphetamine consumption. SNP5 and DIP-zeta were tested for cocaine
consumption. We tested whether the alternative alleles for each SNP had significant
effects on consumption using two-way factorial analyses of variance, where SNP
genotype and sex are the two main effects; we also performed reduced analyses
separately for males and females.
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All but one (path) of the allele-specific AIPs showed significant differences in
consumption between the alternative alleles (Fig. 3.4, Table S3.12). Interestingly, all
other SNP effects were different in males and females. The effects of SNP1, SNP5, sim
and DIP-zeta (cocaine consumption) were sex-specific; and the effects of SNP2, SNP4,
Src64B and qless were sex-antagonistic (Fig. 3.4A-C). The population × sex interaction
was not significant for SNP3 or DIP-zeta (methamphetamine consumption). The H allele
had greater consumption than the C allele for SNP1, SNP3, sim and DIP-zeta (cocaine
and methamphetamine consumption) and for one of the two sexes for SNP2, SNP4,
Src64B and qless (Fig. 3.4A-C). The SNP5 H allele had lower consumption than the C
allele (Fig. 3.4B-C). Genetic variation in sexual dimorphism for voluntary drug
consumption is therefore pervasive not only at the gene level, but also at the level of
individual SNPs.
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Fig. 3.4. Consumption differences in H versus C allele-specific AIPs. Mean
consumption of methamphetamine (A) or cocaine (B) is shown for H and C allelespecific AIP populations. Blue dots represent average consumption for C or H
males; red dots represent average consumption for C or H females. (C)
Differences in consumption of cocaine or methamphetamine (METH) for males
and females in H and C populations for each pair of allele-specific AIPs. Black
indicates the drug was not tested for that SNP/gene. Blue indicates significantly
greater consumption in the H population versus the C population. Red indicates
significantly less consumption in the H population.

Discussion

Rodent models have long been used to study the physiological, molecular, and
behavioral effects of cocaine and methamphetamine, but are not well suited for
identifying causal variants in multiple segregating genes that contribute to susceptibility
to substance abuse because of limitations on sample sizes, extensive linkage
disequilibrium in many mapping populations, and cost considerations. D. melanogaster
has been used previously to dissect the genetic architecture of ethanol consumption
(27), alcohol sensitivity (34), and feeding behavior (35). Here, we used extreme QTL
mapping in an advanced intercross population of D. melanogaster to identify naturally
differentially segregating alleles in individuals with high consumption of sucrose
supplemented with cocaine or methamphetamine. We identified significant variants
within 1 kb of annotated genes and constructed a genetic network associated with
increased consumption of cocaine and methamphetamine. We showed that RNAi of a
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sample of candidate genes from the GWA analyses affected cocaine and/or
methamphetamine consumption for 77% of the genes tested. Our allele-specific AIPs
functionally implicated intergenic and intragenic SNPs associated with drug
consumption. We found extensive genetic variation in sexual dimorphism underlying the
genetic architecture of voluntary cocaine and methamphetamine consumption at the
level of GWA associations, RNAi constructs, and allele-specific AIPs, in line with
previous studies that documented sexual dimorphism for drug consumption traits in D.
melanogaster (20, 36), rodents (39,40) and humans (41).

Previous studies on the effects of cocaine and methamphetamine in Drosophila primarily
focused on behavioral effects of single gene mutants (42,43). Previously, we assessed
natural genetic variation in drug consumption traits in a subset of DGRP lines (20).
However, the small number of lines in that study only enabled detection of common
variants with large effects. Using an AIP and extreme QTL mapping increases statistical
power and enabled us to identify 1307 variants in 988 genes that are associated with
increased consumption of cocaine or methamphetamine, 209 of which were identified in
our previous study, including arr, Eip75B, pum, Tusp, hoe1, Mob2, and kuz (20). These
genes are enriched for biological processes involved in nervous system development,
including axon guidance, axon extension, dendrite morphogenesis, and synaptic target
recognition.

Genes associated with development of the nervous system have been previously
implicated in drug consumption traits in flies (20). Development of the nervous system is
recapitulated in the genetic interaction network we constructed consisting of 77 genes
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(Fig. 3.2B), which shows enrichment for developmental signaling pathways, including
Wnt, Notch, and Hippo (Table S3.6). In mice, Wnt signaling plays a role in cocaineinduced neuroplasticity (44) and cocaine activates Notch signaling by disrupting the
blood-brain barrier (45). Of the 77 genes in this network, 64 contain a human ortholog
(DIOPT ≥ 3). We can construct an interaction network consisting of these orthologs and
computationally recruited genes (Fig. 3.2C), suggesting evolutionary conservation of
fundamental biological processes that underlie variation in susceptibility to
psychostimulants.

We selected 22 candidate genes to assess whether RNA interference would affect
consumption of cocaine or methamphetamine. We found that 17 (77%) of these genes
showed a significant difference in consumption of cocaine or methamphetamine in at
least one sex after RNAi knockdown using a weak ubiquitous driver. Failure of candidate
genes to show an effect on drug consumption upon RNAi knockdown could be due to
functional redundancy, insufficient extent of knockdown (noting that the extent of RNAi
knockdown is not linearly related to the phenotypic effect), or the candidate gene may be
a false positive.

One limitation of RNAi is that it provides a gene-based rather than a SNP-based
validation method and cannot be used to establish causality of intergenic SNPs, some of
which have large phenotypic effects. To validate causal SNPs that contribute to variation
in consumption of cocaine and methamphetamine, we constructed allele-specific AIPs to
isolate alternate alleles of candidate SNPs in randomized genetic backgrounds. This
provided an effective method to validate both intragenic and intergenic SNPs. All but one
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of the AIPs showed significant differences in consumption between the alternative alleles
in at least one of the sexes. For most SNPs, the population containing the “high
consumer” (“H”) allele consumed more drug than the population with the “control” (“C”)
allele in at least one sex. In one case, however, the population containing the H allele
consumed less drug than the population with the C allele, which may be attributable to
epistasis, which is a prominent feature of complex traits (46,47).

All four genes for which we have validated allelic variants that are associated with
variation in cocaine consumption have human orthologs. The single minded (sim) gene
encodes a helix-loop-helix transcription factor which has been identified as a positive
regulator of the midline formation in the embryonic central nervous system (48) and
plays a role in axon guidance in the larval brain (49). DIP-zeta encodes a Dprinteracting protein. The Drosophila genome contains 21 members of the Dpr gene family
and nine paralogs that encode Dpr interacting proteins. These proteins contain
immunoglobulin domains, and unique paired combinations of DPRs and DIPs function
as synaptic partners consolidating neural connectivity (50). Src64B specifies a
cytoplasmic protein tyrosine kinase, which contributes to development of the mushroom
body (51). qless encodes a protein involved in the synthesis of the isoprenoid side chain
of Coenzyme Q, which is a component of the mitochondrial electron transport chain.
Neurons of qless mutants undergo mitochondrial stress and caspase-dependent
apoptosis (52). These observations support the notion that allelic variants of these genes
result in variation in neural connectivity and function, which modulates their propensity to
consume psychostimulants.
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In conclusion, we developed a method for establishing causality of inter- and intragenic
SNPs in outbred populations. Using this approach in combination with RNA interference
we showed that the genetic architecture underlying variation in voluntary cocaine and
methamphetamine consumption is sexually dimorphic and dominated by genes
associated with nervous system development. The use of allele-specific DGRP-derived
AIPs can be generally applied to establishing causality of single candidate SNPs
associated with variation in complex traits. Based on evolutionary conservation of
fundamental cellular pathways, results obtained from the Drosophila gene discovery
model can guide studies on substance abuse susceptibility in human populations.

Materials and Methods

Drosophila stocks

We created an advanced intercross population (AIP) by crossing 37 inbred, wild-derived
D. melanogaster lines from the D. melanogaster Genetic Reference Panel (DGRP) using
a round-robin crossing scheme (27,53,54) followed by over 50 generations of random
mating prior to commencement of these studies. The founder lines were minimally
related, minimally heterozygous, inversion free and free of Wolbachia infection. The AIP
was maintained with 400 randomly selected males and 400 randomly selected females
each generation. Every generation, 40 males and 40 females were randomly selected
from each of 10 bottles and re-distributed at random into 10 bottles to minimize genetic
drift. Flies were allowed to lay eggs for 24 hours to minimize crowding; the adults were
then discarded.

111

We obtained UAS-RNAi lines from the Vienna Drosophila Resource Center (VDRC) for
22 candidate genes (Table S3.13). The P{KK} RNAi lines are from the same genetic
background and contain an upstream activating sequence (UAS) construct at the same
locus on the second chromosome (55). The P{GD} RNAi lines are from the same genetic
background and contain P-element based transgenes in a random insertion site (56).
None of these RNAi lines had predicted off-target effects. We also obtained the coisogenic control lines for the KK (w1118, v600100) and GD (w1118, v60000) RNAi lines
from the VDRC. We generated the Ubi156-GAL4 driver line in house (53). All flies were
maintained on cornmeal-agar-molasses medium at 25ºC, 70% humidity and a 12h:12h
light/dark cycle.

Capillary Feeder (CAFE) assay

Individual three-to-five-day old flies were placed on culture medium for 24 hours, and
then transferred to culture vials containing 1.5% agar medium. Vials were plugged with
blue foam plugs in which a 5 μL capillary tube containing either 4% sucrose or 4%
sucrose supplemented with cocaine or methamphetamine was inserted. A drop of
mineral oil was added to the top of each capillary tube to impede evaporation. Vials were
placed in racks in a humidified chamber to further minimize evaporation. Each humidified
chamber contained “blank” vials containing a capillary but no fly to quantify the
evaporation rate. Fluid level measurements were recorded immediately after the
capillaries were inserted into the vials and after 18 hours of ad libitum feeding (Fig. 3.1).
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The decrease in fluid level was converted to volume consumed following normalization
for evaporation.

Dose response

We performed dose response experiments to determine the appropriate concentration of
cocaine and methamphetamine for consumption in the AIP. We assessed consumption
of sucrose supplemented with 0.05, 0.1, 0.2, 0.3, 1.0 and 3.0 μg/μL cocaine or
methamphetamine for 50 males and 50 females. Mean consumption for each
concentration was calculated and plotted with an S-curve super-imposed on the means.
For each sex and condition, the inflection point was close to a concentration of 1.0
μg/μL. We also performed dose response experiments for the GD and KK RNAi control
lines to determine the optimal concentration of cocaine and methamphetamine for RNAi
validation. We quantified consumption of sucrose supplemented with 0.25, 0.5, 0.75, and
1.0 μg/μL cocaine or methamphetamine for 30 males and 30 females (Table S3.14).
Few flies from these genotypes consumed cocaine or methamphetamine at
concentrations of 0.75 and 1.0 μg/μL; therefore, we selected 0.5 μg/μL cocaine and
methamphetamine for testing the RNAi lines.

Drug consumption in the AIP

We quantified consumption of sucrose, sucrose supplemented with 1.0 μg/μL cocaine,
or sucrose supplemented with 1.0 μg/μL methamphetamine for males and females
separately. Each assay day, the top 10% of consumers for each condition and an equal
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number of random, unexposed flies were separately collected into pools and flash frozen
for DNA sequencing. In total, we quantified consumption for 1,500 males and 1,500
females with two replicates per condition for sucrose, cocaine, and methamphetamine
consumption (18,000 flies total).

Proboscis Extension Response (PER)

Three-to-five-day old AIP flies were collected and placed on culture medium for 24
hours. Flies were then transferred to vials containing non-nutritive 1.5% agar for 24
hours, after which they were anesthetized using CO2, and mounted on a glass slide with
nail polish with the ventral side facing upwards. After a recovery period of 3-6 hours at
25ºC, the flies were tested for their proboscis extension response (PER) (31). Flies were
satiated with water then presented with tastants for two to three seconds, with five to ten
second intervals between tastants. The order of presentation was: water, sucrose, drug,
water, sucrose. Individual flies were only tested with either 1.0 μg/μL cocaine or 1.0
μg/μL methamphetamine. The PER was calculated as the percent of flies that extended
their proboscis in response to the tastant. Only flies that responded to sucrose initially
were recorded. Flies were tested until 100 flies were scored per sex and treatment.
Differences in PER between sucrose and cocaine or methamphetamine were assessed
using a Chi-squared test.

PER was also analyzed for individual three-to-five-day old males and females following
consumption of cocaine or methamphetamine for 18 hours using the CAFE assay. Flies
that did not survive or did not respond to sucrose on the initial presentation were not
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scored. Differences in consumption between extenders and non-extenders were
assessed using a two-tailed t-test.

DNA sequencing

Pools of 150 flies per sample were homogenized using a TissueLyser (Qiagen, Inc.,
Germantown, MD, USA). Genomic DNA was extracted with the Gentra Puregene Tissue
kit (Qiagen Sciences, MD, USA) then fragmented to 350-400 bp using a Covaris S220
Sonicator (Covaris, Inc, Woburn, MA, USA). 100 ng of fragmented DNA were used to
produce barcoded DNA libraries using NEXTflexTM ChIP-seq barcodes (Bioo Scientific,
Inc., Austin, TX, USA). Libraries were quantified using Quant-IT dsDNA HS Kits
(ThermoFisher, Waltham, MA) on a SpectraMax Plate reader and their sizes (bp) were
determined using the 2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA,
USA). All libraries were diluted to 10 nM and all libraries for each replicate were pooled
together, denatured, and diluted to 16 pM. Pools were clustered on an Illumina cBot
(Illumina, Inc., San Diego, CA, USA) and sequenced on eight lanes (four lanes per pool)
on an Illumina HiSeq2500 sequencer (Illumina, Inc., San Diego, CA, USA) using 125 bp
paired-end sequencing. Sequence reads were aligned to the D. melanogaster reference
genome using Burrows-Wheeler Aligner (BWA, version 0.6.2) (56). Low quality bases at
the end were trimmed with the “-q 13” option in BWA. The alignments were locally
realigned, marked for PCR duplicates using GATK (version 2.4) (57) and Picard tools
(version 1.89) before recalibrating base qualities with GATK. Bases passing a series of
quality filters (47) were piled up to obtain counts of alleles at polymorphic sites where the
parental lines segregate.
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Extreme QTL GWA analyses

We performed ‘extreme QTL mapping’ (xQTL) (58) to identify variants for which there
are consistent differences in allele frequencies between randomly selected (C) and high
consumption (H) pools, averaged over both replicates, for sexes separately. We used a
Z test where the null hypothesis is that the allele frequencies between the C and H pools
are equal and the test statistic compares the difference in the estimated allele
frequencies in the C and H pools, taking into account the number of chromosomes in
each pool and the sequencing depths in the C and H pools. The test statistic is Z =
𝑝𝑝1 −𝑝𝑝2

�𝑝𝑝0 (1−𝑝𝑝0 )(1/𝑛𝑛 + 1/𝑐𝑐1 +1/𝑐𝑐2 )

, where p1 and p2 are the allele frequencies in the two pools

respectively, p0 is the average allele frequency of p1 and p2, n is the number of flies in

each pool (n = 150), and c1 and c2 are the sequence coverages in the two pools. Under
the null hypothesis of no difference between p1 and p2, Z is distributed as standard
normal. Evidence for joint association from the two replicate populations was obtained
by calculating a combined χ2 statistic, weighted by sequence coverage, and obtaining Pvalues from the χ2 distribution (59). We tested 2,568,908 SNPs and used a Bonferronicorrected significance threshold of 1.95 x 10-8 to determine significance of individual
variants, separately, for the sexes and three treatments.

Enriched genetic interaction networks

We annotated candidate genes identified in the xQTL analyses using complete genetic
interaction networks from FlyBase (release r5.57) which were curated based on the
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literature. The genes are nodes in the network and the interactions are edges between
the nodes. We mapped significant candidate genes from the xQTL analyses onto this
graphical representation of genetic networks and extracted sub-networks involving the
candidate genes, with no missing nodes. We tested whether the maximum sub-network
is significantly greater than expected by chance using a permutation procedure
(34,60,61). We also constructed a genetic interaction network using the candidate genes
identified in the xQTL analysis and the candidate genes identified in (20) using the same
procedure described above. A genetic interaction network for human orthologs of the
candidate genes in the xQTL analyses was constructed using R-Spider (62). All
networks were visualized using Cytoscape 3.8.0.

Gene Ontology enrichment

Gene ontology (GO) enrichment analyses were performed using the PANTHER
Overrepresentation Test (32) and the GO Ontology database (33).

Human ortholog identification

Human orthologs were obtained using the DRSC Integrative Ortholog Prediction Tool
(63,64).
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RNA interference (RNAi)

We crossed four or five homozygous Ubi156-GAL4 driver males to either 4-7 virgin UASRNAi females or 4-7 virgin females from the appropriate control strain. 40 males and 40
females per genotype and treatment were collected and aged until they were 3-5 days
old. Flies were then separated individually into vials containing culture medium for 24
hours before being transferred to vials containing 1.5% agar medium. Consumption of
4% sucrose, 0.5 µg/µL cocaine plus 4% sucrose, or 0.5 µg/µL methamphetamine plus
4% sucrose was then tested, males and females separately, using the CAFE assay.
Only the treatments that were statistically significant in the AIP were tested.
Consumption differences between RNAi lines and their corresponding control were
assessed separately for each treatment using the fixed-effects ANOVA model Y = µ + S
+ G + S×G + ε and the reduced models Y = µ + G + ε for sexes separately, where Y is
consumption, µ is the overall mean, S is sex (male/female), G is genotype (control/RNAi)
and ε is the error term.

For SNPs/genes where both cocaine and methamphetamine consumption were
quantified, we assessed differences in consumption of cocaine and methamphetamine
using the fixed-effects ANOVA model Y = µ + S + G + T + S×G + S×T + G×T + S×G×T +

ε where S and G are sex and genotype as mentioned above, and T is treatment
(cocaine or methamphetamine).
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Allele-specific AIPs and drug consumption

We constructed 10 pairs of allele-specific AIPs: one AIP for the high-consumer (H) allele
or the alternate/control (C) allele for each of 10 candidate SNPs or haplotypes. For each
allele-specific AIP we chose 10 independent DGRP lines containing the candidate allele
that were not used as parental lines for the original AIP. We used the same round-robin
crossing scheme described above and maintained all AIPs with 400 randomly selected
males and 400 randomly selected females exactly as described above. These lines were
maintained for over 35 generations prior to quantification of consumption phenotypes.
We tested 150 three- to five-day old flies per sex and condition for consumption of the
drug for which the SNP was significant in the original xQTL analysis. To assess
differences in consumption between the alleles at each tested locus, we used the twoway factorial fixed effects ANOVA model Y = µ + S + G + S×G + ε and the reduced
model Y = µ + G + ε for sexes separately, where Y is consumption, µ is the overall
mean, S is sex (male/female), G is genotype (C versus H) and ε is the error term.
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Introduction

Cocaine use presents a significant socioeconomic health problem (Substance Abuse
and Mental Health Services Administration 2019; Kariisa et al. 2019). While cocaine
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use results in arousal and euphoria, side effects include accelerated heart rate, mood
swings, difficulty sleeping, loss of appetite and cognitive distortions. Escalated
consumption of cocaine can result in psychosis, cardiovascular disease and stroke.

The propensity for cocaine use depends on genetic and environmental factors. Whereas
much is known about the neurological effects of cocaine, information about genetic
variants that are associated with variation in individual susceptibility to psychostimulant
use remains incomplete. Furthermore, little is known about acute effects of cocaine
consumption on genome-wide gene expression across the brain.

Drosophila melanogaster presents an advantageous model system for systems genetic
analyses of cocaine consumption (Kaun et al. 2012). Flies can be reared rapidly in large
numbers at low cost in defined genetic backgrounds and under controlled environmental
conditions, and about 75% of disease-causing genes in humans have fly orthologs
(Pandey and Nichols 2011). The crystal structure of the Drosophila dopamine
transporter has been obtained and its binding site can accommodate cocaine (Wang et
al. 2015). Exposure of cocaine elicits motor responses that resemble behaviors
observed in rodents, and flies develop sensitization to repeated intermittent exposure to
cocaine (McClung and Hirsh 1998; Filošević et al. 2018). Dopamine (Bainton et al.
2000), the dDAT dopamine transporter (Wu and Gu 2003) and the dSERT1 serotonin
transporter (Corey et al. 1994; Demchyshyn et al. 1994; Borue et al. 2009 and 2010)
have been implicated in mediating cocaine-induced behaviors in flies (Li et al. 2000;
Simon et al. 2009). Consistent with the actions of these neurotransmitters,
overexpression of the vesicular monoamine transporter in both dopaminergic and
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serotonergic neurons decreases the response to cocaine (Chang et al. 2006). Thus,
fundamental neural mechanisms affected by exposure to psychostimulants are
conserved across phyla, from flies to humans.

Studies on inbred wild-derived, fully sequenced lines of the Drosophila melanogaster
Genetic Reference Panel (Mackay et al. 2012; Huang et al. 2014) identified candidate
genes associated with variation in consumption and development of preference for
cocaine and methamphetamine (Highfill et al. 2019). Targeted RNA interference (RNAi)
of gene expression implicated dopaminergic neurons and the mushroom bodies, central
brain structures associated with experience-dependent modification of behavior, with
consumption and development of preference for these psychostimulants (Highfill et al.
2019). However, RNAi-mediated reduction in expression of candidate genes in glia also
affected cocaine consumption, suggesting that widespread brain regions contribute to
cocaine-associated behavioral phenotypes. The present study aims to delineate the
effects of acute cocaine consumption on genome-wide gene expression across the
Drosophila brain.

Results

Cocaine consumption causes behavioral impairments

To assess the effects of acute cocaine exposure on fly behavior, we allowed males and
females to ingest a fixed amount of sucrose or sucrose supplemented with cocaine
within a maximal two-hour time period. We measured negative geotaxis, an innate
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locomotor behavior, to assess locomotion impairments, and startle behavior as a
measure of sensorimotor integration (Figure 4.1; Supplemental Table S4.1). Male flies
exposed to cocaine took longer to climb in the negative geotaxis assay than control flies,
while females appeared unaffected (Figure 4.1A). Both male and female flies exposed
to cocaine spent less time moving after being subjected to a mechanical disturbance
(Figure 4.1B; Supplemental Video S4.1). The average reduced locomotor activity in
both assays might result from excessive grooming behavior in a fraction of male flies
exposed to cocaine (Figure 4.1C and D; Supplemental Video S4.2). In addition, we
observed seizures in a small percentage of flies after cocaine intake during the negative
geotaxis assay (Supplemental Video S4.3). Seizures rarely occurred in controls (Figure
4.1C and D). Collectively, these experiments provide evidence that acute exposure to
cocaine results in neurological impairments.
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Figure 4.1: Behavioral characterization of Canton-S B flies after cocaine
exposure. (a) Negative geotaxis. The 7.5cm climb time for each fly was
measured (n = 120 (♀control), 114 (♀cocaine), 141 (♂control), 128 (♂cocaine)).
Horizontal lines represent means with standard error. Male flies exposed to
cocaine took longer on average to climb compared to controls (*,P = 0.0042, two
tailed Student’s t-test). (b) Startle response. The percent time out of 45 seconds
that each fly spent moving following a 42 cm drop was measured (n = 155
(♀control), 145 (♀cocaine), 120 (♂control), 123 (♂cocaine)). Horizontal lines
represent means with standard error. Flies exposed to cocaine spent less time
moving on average than controls (for females ***, P = 4.68 × 10-6; for males ***,P
= 7.62 × 10-13; two tailed Student’s t-test). (c) Seizures and grooming activity
during negative geotaxis. The percent of flies that exhibited seizures or grooming
activity during the negative geotaxis assay after exposure to cocaine was
measured (n = 142 (♀control), 141 (♀cocaine), 166 (♂control), 161 (♂cocaine)).
Both females and males exposed to cocaine exhibited seizure activity more than
controls (for females *,P = 0.0361; for males seizure: ***, P = 0.0007; Fisher’s
exact test). Males exposed to cocaine also exhibited excessive grooming activity
more than controls (grooming: ***, P = 0.0007; Fisher’s exact test), but females
did not show statistically significant differences. (d) Seizures and grooming
activity during the startle response. The percent of flies that exhibited seizures or
grooming activity during the startle assay after exposure to cocaine was
measured (n = 155 (♀control), 145 (♀cocaine), 120 (♂control), 123 (♂cocaine)).
Female flies exposed to cocaine exhibited more seizure activity than controls (*,
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P = 0.0121; Fisher’s exact test), while male flies exposed to cocaine exhibited
more grooming activity than control (***, P = 0.00001; Fisher’s exact test).
Single cell RNA-seq reveals cocaine-modulated gene expression in neurons and glia
To assess effects of cocaine consumption on brain gene expression, we analyzed single
cell transcriptional responses in duplicate samples of flies that consumed fixed amounts
of sucrose or sucrose supplemented with cocaine in both males and females
(Supplemental Table S4.2). Visualization of the resulting integrated dataset using the
Uniform Manifold Approximation and Projection (UMAP) non-linear dimensionality
reduction method (Becht et al. 2019) showed that no single cluster was dominated by a
specific sample, sex, condition or replicate and that there was considerable homogeneity
(i.e., an even distribution of cells from samples) across the entire dataset (Supplemental
Figure S4.1). We identified 691 differentially expressed genes in males and 322 in
females following acute exposure to cocaine, of which ~69% have human orthologs
(Supplemental Table S4.3). Unsupervised clustering of the integrated dataset based on
the expression profiles of individual cells resulted in 36 distinct, stable clusters (Figure
4.2). We assessed the stability of clustering by examining the relationship between the
number of new clusters identified and the granularity resolution parameter (Butler et al.
2018). At a resolution of 0.8, the number of clusters stabilized and the resolution had to
be increased significantly from this value in order to add new clusters, indicating that
saturation in the diversity of expression profiles had been reached.
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Figure 4.2. UMAP visualization and clustering of single-cell expression
data. Cells were clustered based on their expression pattern using the
unsupervised shared nearest neighbor (SNN) clustering algorithm. Individual
dots represent each cell and the colors of the dots represent the cluster to which
the cells belong. Identification of cell types from clusters was performed by crossreferencing cluster-defining genes across FlyBase (Thurmond et al. 2019) and
published literature (see Supplemental Table S4.4).
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We identified cell types corresponding to each cluster using the top marker genes from
each cluster, obtained by comparing each cluster’s gene expression profile against the
rest of the dataset and filtered by |logeFC| > 0.5, Bonferroni adjusted P value < 0.05.
Annotation of clusters based on their gene markers revealed that all major cell types
(neuronal and glial) as well as neurotransmitter types from most brain regions, including
the mushroom bodies, were represented (Figure 4.2, Supplemental Table S4.4).
Differential expression analysis within individual clusters indicated cluster-specific
transcriptional responses to cocaine. Especially, clusters corresponding to glia and
Kenyon cells of the mushroom bodies showed transcriptional responses following
cocaine exposure (Figure 4.3A and B). Thus, acute exposure to cocaine elicits rapid
widespread changes in gene expression throughout the brain.
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Figure 4.3. Distribution of differentially expressed genes across clusters in
males (A) and females (B) exposed to cocaine and Venn diagrams showing
overlap between differentially expressed genes in males and females (C).
To identify clusters with unique gene expression patterns following acute
exposure to cocaine, we filtered the list of differentially expressed genes to only
show the strongest responses (|logeFC| > 1.0, Bonferroni adjusted P value <
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0.05) to construct an expression matrix. Differentially expressed genes are listed
on the top (columns) and cell clusters are represented by the rows. Magenta
boxes show upregulation and turquoise boxes show downregulation of gene
expression as a result of exposure to cocaine. Panel C shows Venn diagrams of
clusters with sexually dimorphic responses to cocaine exposure. The numbers
within each Venn diagram represent the unique and shared differentially
expressed (|logeFC| > 0.5, Bonferroni adjusted P value < 0.05) genes due to
cocaine exposure from DGE analysis performed for the corresponding cluster in
male and female datasets separately.

Cocaine-modulated changes in gene expression are sexually dimorphic

We first analyzed differential expression by combining the male and female samples.
There was a significantly greater number of genes upregulated than downregulated
across all clusters in response to cocaine. Based on the number of strongly differentially
expressed genes (|logeFC| > 1, Bonferroni adjusted P value < 0.05), clusters
corresponding to surface glia (C22), unannotated cluster C16, astrocytes (C17) and
Kenyon cells (C11) showed the largest responses to cocaine (Supplemental Figure
S4.2). In addition, a core set of genes, selected based on their ranks from the TopKList
consistency analysis (Schimek et al. 2015), show that they responded globally to
cocaine exposure (Supplemental Table S4.5). These genes include Rpl41, IA-2, and the
long noncoding RNAs CR34335 and CR34094, which were upregulated; and roX2 and
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ninaE, which were downregulated after consumption of cocaine (Supplemental Figure
S4.2, Supplemental Table S4.5 and S4.6).

Examination of males and females separately revealed extensive sexual dimorphism in
the response to cocaine. Consistent with effects on organismal phenotypes (Figure 4.1),
males showed more widespread changes in cocaine-modulated transcript abundances
than females (Figure 4.3A and B), When we consider only highly differentially expressed
genes (|logeFC| > 1.0, Bonferroni adjusted P value < 0.05), we can construct expression
matrices of 133 genes in males (Figure 4.3A) and 54 genes in females (Figure 4.3B).
Clusters C11 (Kenyon cells), C16 (not annotated), C17 (astrocytes) and C22 (surface
glia) had unique responses compared to the rest of the clusters in both males and
females; C22 shows the most extensive cocaine-induced changes in transcript
abundances in males (Figure 4.3A). In addition to differences in the magnitude of
cocaine-modulated gene expression between the sexes, we also observe differences in
direction, in which upregulation in one sex corresponds with downregulation in the other.
Overall, there was little overlap between the sexes - especially in clusters C10, C12,
C15, C16, C19 and C22 (Figure 4.3C, Supplemental Table S4.7, S4.8 and S4.9). Thus,
although cocaine-modulated changes in gene expression are widespread throughout the
brain in both sexes, specific changes in transcript abundances are distinct between
males and females.
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Co-expression networks highlight effects of cocaine on diverse cellular processes

Reactome analysis of pathway enrichment (Fabregat et al. 2016) in C11 and C20 in
females, which based on biomarkers represent Kenyon cells of the mushroom bodies,
highlighted inositol phosphate metabolism (Supplemental Table S14.0), suggesting a
role for cocaine in modulating signal transduction. We were unable to assign a specific
identity to C16, which might be comprised of a mixture of neurons from the antennal lobe
and optic lobe (Supplemental Table S4.4). However, pathway analysis of male C16
revealed enrichment of multiple signal transduction pathways, including pathways
related to G-protein coupled receptor signaling, activation of serotonin and AMPA- and
NMDA-type glutamate receptors, activation of axonal growth inhibition, and Class A/1
Rhodopsin-like receptor signaling (Supplemental Table S4.10).

In contrast to the signal transduction elements associated with the neuronal C11 and
C16 clusters, different cellular mechanisms are associated with cocaine exposure in C17
and C22, which represent astrocytes and surface glia, which comprise the blood-brain
barrier in the fly, respectively (Supplemental Table S4.10). Functional enrichment
analysis yielded few differentially expressed genes for females, but for C22 in the male
dataset revealed enrichment of Notch activation and signaling, degradation of GABA,
immune pathways related to NF-κB activation, cytokine production and Toll-like receptor
signaling, and nonsense mediated decay and translation initiation (Supplemental Table
S4.10). These observations are in line with expected functions of glia (Kremer et al.
2017).
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We used Random Matrix Theory (RMT; Gibson et al. 2013) to construct co-expression
networks of cocaine-modulated differentially co-expressed genes for selected clusters
with enough differentially expressed input genes. Across all cell clusters we find genes
of unknown function and genes encoding long non-coding RNAs, which are likely to play
a regulatory role (Everett et al. 2020). We present examples of co-expression networks
for C16 males (Figure 4.4A-C and Supplemental Figure S4.3) and C22 males (Figure
4.4D and Supplemental Figure S4.4).
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Figure 4.4: Sub-networks from co-expression network analyses of DEGs
from the male C16 and C22 clusters. Networks are constructed from Pearson
Coefficient based co-expression values calculated from scaled data of genes that
were differentially expressed (filtered for |logeFC| > 0.5, Bonferroni adjusted P
value < 0.05) due to cocaine exposure. Co-expressions have been filtered using
Random Matrix Theory. (a-c) MCODE sub-networks derived from the full network
of male cluster C16. The inset in (a) corresponds to a subset of genes within the
sub-network that have very strong correlation coefficient values with each other
compared to the rest of the dataset. Colors of the dots represent the connectivity
index derived from MCODE scores. Colors of edges represent the positive (red)
and negative (green) correlations. (d) Co-expression network analysis of DEGs
from the male C22 cluster.

Co-expression analysis for C16 reveals a highly interconnected network that could be
partitioned into three subnetworks using Molecular Complex Detection (MCODE)
stratification (Bader and Hogue). Central genes include transcriptional regulators
associated with development, including dendrite morphogenesis (Lim1, jim) as well as
signal transduction (5-HT2A, CNMaR; Figure 4.4A and Supplemental Figure S4.3).
Random Matrix Theory identified two major subnetworks within the interaction network
that represents C22 (Figure 4.4D and Supplemental Figure S4.4). The two subnetworks
in C22 were connected by only three genes (CG3168, CG10433 and CG15209) through
negative correlation (Figure 4.4D and Supplemental Figure S4.4). Of the three genes,
CG3168, which belongs to the SLC22 family of organic ion transporters, had the largest
number of negative correlations linking the two large subnetworks. This gene is
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expressed in the blood-brain barrier of flies and postulated to play a role in
chemoprotection of the brain (Hindle and Bainton 2014). Further stratification using the
MCODE algorithm resulted in three tightly clustered C22 subnetworks. The C22 male
interaction network comprises genes associated with oxidation-reduction (se, Ssadh)
and redox reactions, particularly the glutathione system (GstE12, GstE14, se), as well as
cell adhesion (SPARC, bdl, Tsp, Fas2).

Finally, we assessed interaction networks among differentially expressed genes across
all cell clusters separately for males and females (Figures 4.5 and 4.6). The global
transcriptional response to cocaine in males is captured by a complex network of
interconnected modules (Figure 4.5). Functional analyses reveal modules associated
with Toll-like receptor signaling, ABC xenobiotic transporters and ATPase ion pumps,
translation initiation, and hexose transport, G-protein coupled receptor signaling and
clathrin-mediated endocytosis. The female network has fewer genes and contains
modules associated with phototransduction, lipid receptors and transport, and
glutathione metabolism and neurotransmission (Figure 4.6). In each network, multiple
cell clusters contribute to the organization of each network module, indicating that the
transcriptional response to cocaine is coordinated not only within, but also across
different cells throughout the brain.
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Figure 4.5: Interaction network analysis of DEGs from all clusters in the
male dataset. Network constructed from interactions calculated using StringApp
plugin within Cytoscape for genes that were differentially expressed (filtered for
|logeFC| > 0.1 and Bonferroni adjusted P value < 0.05) in all clusters from the
male dataset. Grey edges represent interactions. Genes that were differentially
expressed in multiple clusters are depicted as pie-charts with each color
representing the respective cluster. Genes are grouped into circles based on
their MCODE connectivity scores. Annotations of these circular groups represent
the pathways that are enriched for the genes within these groups. Bonferroni
adjusted P value < 0.05 was considered as significant for enrichment in the
statistical overrepresentation tests.
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Figure 4.6: Interaction network analysis of DEGs from all clusters in the
female dataset. Network constructed from interactions calculated using
stringApp plugin within Cytoscape for genes that were differentially expressed
(filtered for |logeFC| > 0.1 and Bonferroni adjusted P value < 0.05) in all clusters
from the female dataset. Grey edges represent interactions. Genes that were
differentially expressed in multiple clusters are depicted as pie charts with each
color representing the respective cluster. Genes are grouped into circles based
on their MCODE connectivity scores. Annotations of these circular groups
represent the pathways that are enriched for the genes within these groups. BH–
FDR adjusted P value < 0.05 was considered as significant for enrichment in the
statistical overrepresentation tests.
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Discussion

Unlike humans and rodent models of substance abuse, Drosophila enables
comprehensive single cell transcriptomics analyses of living cells across the entire brain
in a single analysis (Davie et al. 2018). We generated an atlas of cocaine-modulated
gene expression changes in the fly brain and found that transcriptional changes in
response to acute consumption of cocaine are rapid, widespread in both neurons and
glia, and sexually dimorphic. We performed the experiments in duplicate to establish
cross-validation. Transcript abundance levels are influenced by circadian time (ClaridgeChang et al. 2001; Sivachenko et al. 2013; Krzeptowski et al. 2018). Therefore, we
performed all experiments within a defined window of circadian time. Since the
transcriptional profiles we obtained provide a single ‘snapshot’ in time, we cannot extract
information about the temporal progression of the transcriptional response to cocaine to
determine whether or to what extent transcriptional responses in different cell
populations occur sequentially or in parallel. Also, we cannot draw inferences as to
which changes in gene expression might lay a foundation for development of cocaine
preference (Highfill et al. 2019), since we only assessed acute transcriptional responses
following a single exposure to cocaine.

The response to cocaine is sexually dimorphic

Previous studies on the Drosophila melanogaster Genetic Reference Panel (Mackay et
al. 2012; Huang et al. 2014) have documented sexual dimorphism in the genetic
architectures of a wide range of morphological (Zwarts et al. 2015), life history (Nuzhdin
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et al. 1997; Huang et al. 2020) and behavioral traits (Shorter et al. 2015; Harbison et al.
2019), including cocaine consumption and preference (Highfill et al. 2019). However,
sexual dimorphism in the transcriptional response following acute exposure to cocaine is
extreme compared to any previous studies and is mirrored and consistent with the
behavioral phenotypes (Figure 4.1). It is possible that differences in cocaine metabolism
between males and females may contribute to this sexual dimorphism. The sexual
dimorphism we observe is in line with previous studies that show reduced locomotion
and increased grooming in flies given low doses of cocaine, with males showing greater
impairments in behavior (McClung and Hirsch 1998). We note, however, that changes in
gene expression are not a priori necessary for cocaine to elicit behavioral effects.

Cocaine-modulated gene expression in the mushroom bodies

Transcriptional effects of cocaine exposure are evident in all cell clusters, but among
neuronal populations, the Kenyon cells of the mushroom bodies (represented by C11
and C20) have especially large responses to cocaine. The mushroom bodies are
integrative centers associated with experience-dependent modulation of behavior and
have previously been implicated in development of preference for cocaine intake (Highfill
et al. 2019). Acute cocaine consumption leads to changes in gene products associated
with signal transduction, including phosphatidyl inositol mediated signaling in C11 in
males (Supplemental Table S4.10), as well as cyclic AMP mediated signaling, which is
evident from increased expression of rutabaga (rut), in C20 in females (Supplemental
Tables S4.8 and S4.10). rut encodes a calcium-calmodulin dependent adenylyl cyclase,
implicated in learning and memory (Levin et al. 1992) and behavioral responses to
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ethanol (Rodan et al. 2002; Xu et al. 2012). cpx, which is involved in the functioning of
the SNARE complex at the synapse (Scholz et al. 2019) and may affect
neurotransmission, is upregulated in males in response to cocaine. Kenyon cells receive
dopaminergic input, and acute exposure to cocaine results in altered expression of Ddc,
which encodes DOPA decarboxylase, and downregulation of Dop2R, which encodes a
dopamine receptor in C11 in females (Supplemental Table S4.8). slo, which regulates
neurotransmitter release at synapses (Jepson et al. 2014), is upregulated in response to
cocaine, as is Rgk1, which plays a role in negative regulation of calcium channel activity
(Murakami et al. 2017). Downregulation of jdp can lead to dopamine blockade through
its activity as a co-chaperone in synaptic vesicle release (Ye et al., 2004). Based on the
collective data, cocaine-induced modulation of gene expression appears to result in
altered synaptic regulation in the mushroom bodies.

Cocaine-modulated gene expression in glia

In addition to cocaine-modulated changes in gene expression in neurons, acute
exposure to cocaine results in altered transcript abundances in different populations of
glia (C13, C17, C19, C22), including surface glia (C22) and astrocytes (C17). Mutants of
moody, which encodes two G-protein coupled receptor isoforms localized to surface glia,
have increased sensitivity to cocaine (Bainton et al. 2005). The surface glia, represented
by perineurial and subperineurial glia, act as the blood-brain barrier (DeSalvo et al.
2014; Kremer et al. 2017) and mediate the innate immune response (Kounatidis and
Chtarbanova 2018). Genes associated with the blood brain barrier in Drosophila are also
upregulated in response to cocaine. This includes ogre, which regulates gap junction
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channel activity (Holcroft et al. 2013; Spéder and Brand 2014) and Nrg, which plays a
role in cell adhesion in the blood brain barrier (Kanda et al. 2019), in females.

Acute exposure to cocaine causes changes in expression of genes involved with Tolllike receptor (TLR) signaling, nuclear factor kappa B (NF-kB) activation, cytokine
production, and glutathione metabolism (Figures 4.5 and 4.6). TLR signaling has been
associated with response to cocaine (Zhu et al. 2018), likely due to the interaction of
cocaine with TLR on microglia (Northcutt et al. 2015), and cocaine activates the NF-kB
pathway in the nucleus accumbens of mice (Russo et al. 2009; Muriach et al. 2010).

Astrocytes provide metabolic support for neurons (Tsacopoulos and Magistretti 1996)
and regulate neuronal NMDA receptors and synaptic plasticity (Haydon et al. 2009).
Glutamatergic neurons feature prominently in C1, C3, C21 and C33. Studies on rats
have shown that cocaine is toxic to astrocytes and that loss of astrocytes leads to
dysfunctional neuron-glia communication (Badisa et al. 2013, 2014 and 2015). Eaat1,
which is highly expressed in astrocytes (Supplemental Table S4.4), encodes a
transmembrane glutamate transporter involved in glia-neuron communication
(MacNamee et al. 2016). Eaat1 is downregulated in response to cocaine in males and
has been associated with lifespan (Mazaud et al., 2019), long term memory (Matsuno et
al. 2019), seizures (Jen et al. 2005; Cho et al. 2018) and ataxia (Jen et al. 2005;
Parinejad et al. 2016). Episodic ataxia due to a mutation in this gene (Parinejad et al.
2016) suggests that altered expression of Eaat1 in astrocytes could play a role in
cocaine-induced locomotor effects.
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Translating findings from the Drosophila model to cocaine sensitivity in humans

Like flies, people show sexually dimorphic effects of cocaine use. Although substance
use disorders are more prevalent in males, females are more likely to escalate their drug
usage to the compulsive stage faster than males (Westermeyer and Boedicker 2000;
Haas and Peters 2000), report more negative effects during withdrawal, and have
greater relapse than males (Becker and Koob 2016). Females metabolize cocaine faster
than males, as evident from lower levels of cocaine metabolites in the bloodstream of
females compared to males who have consumed equal amounts of cocaine (Lukas et al.
1996). In this same study, males experienced the effects of cocaine faster and with
greater intensity than females. In rats, differences in sex hormones and the estrous cycle
contribute to differences in sensitivity to cocaine (Becker and Koob 2016; Cao et al.
2018). Thus, sexual dimorphism is a universal feature of the physiological response to
cocaine.

Although the Drosophila brain is anatomically distinct from the vertebrate brain,
fundamental neural processes are evolutionarily conserved. Functions of the dopamine
reward pathway in humans are analogous to experience-dependent modulation of
behaviors by the mushroom bodies. In our study, ~69% of genes differentially expressed
in response to cocaine have human orthologs (Supplemental Table S4.3), including
Aldh, Dop2R, GluRIA, GluRIB, and Vmat, previously implicated in cocaine phenotypes.
Polymorphisms in the human ortholog for Aldh, ALDH2, have been associated with drug
addiction in Chinese populations (Zhang et al. 2017), and suppression of ALDH2
suppresses cocaine seeking behavior (Yao et al. 2010). Dop2R encodes a dopamine
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receptor, and its human ortholog, DRD2, is a well-characterized component of the
dopamine reward pathway, which mediates development of cocaine dependence (Noble
et al. 1993; Persico et al. 1996; Moyer et al. 2011; Stolf et al. 2019). The glutamate
receptor genes GluRIA and GluRIB are associated with glutamatergic
neurotransmission, which is altered following exposure to cocaine and has been linked
to cocaine sensitization and cocaine-induced behavioral effects (Ghasemzadeh et al.
2011; Liu et al. 2014; Shin et al. 2016). Vmat encodes the vesicular monoamine
transporter responsible for packaging the neurotransmitters dopamine, serotonin and
octopamine in synaptic vesicles (Greer et al. 2005). The vesicular monoamine
transporter in humans, VMAT2 encoded by the SLC18A2 gene, has the same function,
and VMAT2 protein levels are reduced in cocaine users (Little et al. 2003; Narendran et
al. 2014). These functional parallels between the fly model and human studies provide
proof of principle that results from cocaine exposure obtained from the fly model can be
translated to human populations. Thus, the comprehensive documentation of cocaine
mediated modulation of gene expression which we have derived can serve as a
contextual framework for future human studies.

Methods

Drosophila stock

Canton S (B) flies (Norga et al. 2003) were maintained on standard
cornmeal/yeast/molasses-agar culture medium at 25°C on a 12:12 hour light:dark cycle
with 50% humidity in controlled adult density vials to prevent overcrowding. Briefly, 5
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males and 5 females were placed into a vial and allowed to mate for two days before
being cleared. Progeny from these vials were collected after eclosion and aged for 3-5
days before experimentation.

Cocaine exposure

Cocaine.HCl was obtained from the National Institute on Drug Abuse under Drug
Enforcement Administration license RA0443159. To expose flies to cocaine, we
performed a modified version of the capillary feeder (CAFÉ) assay (Ja et al. 2007). We
collected the first 40 flies that consumed 0.53 µL of cocaine and the first 40 flies that
consumed 0.53 µL of sucrose, corresponding to an 8 mm reduction in the height of the
solution in the capillary. All experiments were carried out between 8 AM and 11 AM.
Flies were allowed to feed for no more than 2 hours.

Behaviors

We measured negative geotaxis and startle response of individual flies within a 10minute time-frame immediately following acute exposure to cocaine in the CAFÉ assay.
We quantified grooming and seizures in addition to measuring the behavioral response
in each assay. Excessive grooming was defined as more than 10 seconds of constant
grooming (Video S4.2). Seizure activity was defined as severe muscle tremors that
prevented the fly from moving normally (Video S4.3).
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Brain dissection and dissociation

Brains were dissected from each fly immediately after it consumed the designated
amount of sucrose or cocaine solution and we used a dissociation protocol modified
from Croset et al. (2018) and Davie et al. (2018). We collected eight samples of 20
brains from males and females exposed to cocaine or sucrose, with two biological
replicates per treatment and sex. We proceeded with GEM generation using the
Chromium controller (10x Genomics, Pleasanton, CA) if we had a live cell count of > 500
live cells/µl.

Library preparation and sequencing

We made libraries after GEM generation in accordance with 10x Genomics v3.1
protocols. We sequenced the final libraries on an S1 flow cell using a NovaSeq
(Illumina, Inc., San Diego, CA) according to the manufacturer’s instructions.

FASTQ generation, demultiplexing and alignment

The mkfastq pipeline within Cell Ranger v3.1 (10x Genomics, Pleasanton, CA) was used
to convert BCL files from the sequence run folder to demultiplexed FASTQ files. Release
6 version of the Drosophila melanogaster reference GCA_000001215.4 from NCBI
GenBank was indexed using the mkref pipeline and used for alignment using the count
pipeline within Cell Ranger v3.1 with the expected cell count parameter set to 5,000
cells. The sequencing and alignment summary is given in Supplemental Table S4.2.
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Preprocessing, integration and cell-type clustering

Raw expression counts output for each sample from the Cell Ranger pipeline was
imported and analyzed using the Seurat v3 package in R (Butler et al. 2018; R core
team 2013). Genes expressed in less than 5 cells and cells with less than 300 or
greater than 2500 RNA features were filtered out. The upper (2500) and lower (300)
thresholds for the RNA features per cell were chosen based on the recommendations
from the developers of the Seurat v3 Pipeline. The recommendation is based on the
multitude of observations indicating that cells with less than 300 RNA features tend to
have very sparse and unreliable signal and those with greater than 2500 RNA features
tend to be miscalled multiplet cells. Normalization and subsequent integration were
performed using scTransform pipeline (Hafemeister and Satija, 2019). To identify the
cell-type clusters within the dataset, unsupervised clustering using the FindClusters
function and a resolution of 0.8 was used. Cluster marker genes were identified using
FindAllMarker function (min.pct=0.25, logfc.threshold = 0.5, only.pos = TRUE).The top
three genes with positive expression for each cluster were extracted and used for celltype characterization.

Differential expression

Differential expression was performed for each cluster in two ways: (i) after combining
male and female samples together to test for effects of cocaine that are common to both
sexes; and (ii) testing for effects of cocaine in males and females separately to identify

155

sexually-dimorphic responses. The Pearson residuals output from scTransform pipeline
was used as input for differential expression (DE) calculation (Hafemeister and Satija,
2019). The MAST algorithm was used as the testing methodology in the FindMarkers
function (test.use = "MAST", assay = "SCT", slot = "scale.data") for each cluster to
calculate DE. Clusters with sufficient number of DEGs were subjected to pathway
enrichment analysis using the statistical overrepresentation test using the PantherDB
(Thomas et al. 2003) and Reactome databases (Fabregat et al. 2016). Pathways with
BH-FDR adjusted P values < 0.05 were considered statistically enriched.

Simulation of bulk RNA-seq response

The results from DE calculation from the combined dataset were used to determine
which genes were consistently upregulated and downregulated, respectively, across all
clusters as a result of exposure to cocaine. The top 50 ranked differentially upregulated
genes for each cluster and the top 20 ranked differentially downregulated genes for each
cluster were input into TopKLists R package (Schimek et al. 2015).

Cluster-specific co-expression networks

The scaled data from the scTransform pipeline for differentially expressed genes from
clusters 16 and 22 were extracted for the male samples. These scaled data were used
as input for filtering through Random Matrix Theory (RMT; Gibson et al. 2013). The
correlations that passed the filtering process were visualized using Cytoscape version
3.7.2. The MCODE algorithm (Bader et al. 2003) was utilized to identify highly
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interconnected modules within the larger cluster network. Genetic interaction networks
were constructed by converting the gene IDs to gene names/symbols using the FlyBase
Consortium’s ‘Query-by-symbols/ID’ tool and calculating interactions between gene
products using the stringApp plugin within Cytoscape (Doncheva et al. 2019). To
identify specific pathways that are enriched in genes within each of the circular groups,
we performed statistical overrepresentation tests on the gene IDs from each group using
the PantherDB (Thomas et al. 2003) and Reactome (Fabregat et al. 2016) databases.
Pathways with BH-FDR adjusted P values < 0.05 were considered statistically enriched.

Data access

All single-cell RNA sequences data generated in this study have been submitted to the
NCBI Gene Expression Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/) under
accession number GSE152495. R code that was used to perform Seurat-based
analyses with TopKList is included in Supplemental Code and has been submitted to
GitHub under https://github.com/vshanka23/The-Drosophila-Brain-on-Cocaine-at-SingleCell-Resolution/blob/master/Rcode_for_analyses.R .
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CONCLUSIONS AND DISCUSSION

In this thesis, I highlighted experiments that investigate the genetic underpinnings of
cocaine and methamphetamine consumption. In chapter II, I presented a series of
experiments that utilized a selection of inbred Drosophila melanogaster lines to perform
a genome-wide association study for cocaine and methamphetamine consumption traits.
Specifically, these experiments highlighted genes and brain regions that are associated
with consumption of and preference for cocaine and methamphetamine versus sucrose
and answered the question of what genes contribute to initial preference and change in
preference for cocaine or methamphetamine. Chapter III discussed experiments that
found and validated individual SNPs that are associated with increased consumption of
cocaine or methamphetamine. These experiments highlighted the importance of nervous
system development genes in susceptibility to consume cocaine and methamphetamine.
It also revealed the value of advanced intercross populations for validation of individual
SNPs. Finally, chapter IV highlighted the importance of glia and neurons in the
mushroom body in the immediate response to acute exposure to cocaine. The results
from all of these experiments reveal the extensive sexual dimorphism and underlying
genetic architecture of cocaine and methamphetamine consumption traits.

Until now, experiments investigating the effects of cocaine and methamphetamine in
flies have been limited to behavioral studies, looking only at behavioral effects or how a
small number of genes influence behavior (McClung and Hirsh, 1998; Torres and
Horowitz, 1998; Bainton et al., 2000; Rothenfluh and Heberlein, 2002; Wolf and
Heberlein, 2003; Dimitrijevic et al., 2004; George et al., 2005; Andretic et al., 2005;
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2008; Walters et al., 2012; Rigo et al., 2020). Here, we performed the first set of
genome-scale experiments using psychostimulants in flies aimed at identifying genetic
networks that underly the effects of both cocaine and methamphetamine use.
Previously, no genome-scale experiments, in any model system, have been performed
with cocaine and methamphetamine simultaneously. Both of these drugs are central
nervous system psychostimulants with similar mechanisms of action, increasing
extracellular monoamines (Howell & Kimmel, 2008; Favrod-Coune & Broers, 2010;
Panenka et al., 2013). Thus, it is likely that the underlying genetic architecture of use of
these drugs contains similar networks that are regulated in a similar manner. These
experiments allow this question of overlap to be investigated for the first time under the
same experimental conditions, at the same time. Across multiple experiments, we see
that many of the same genes and genetic pathways are involved in the response to both
cocaine and methamphetamine.

Looking across all experiments, we can incorporate many biological levels of information
to see the genes that contribute and respond to cocaine and methamphetamine.
Combining the findings from the GWAS, xQTL mapping, and single-cell experiments, we
observe 248 genes that overlap between all experiments. When we ask to what extent
these genes are known to interact in previously curated genetic interaction networks, by
computationally recruiting missing genes, we identify a significant (P < 0.001) network of
153 genes (80 computationally recruited; Figure 5.1). The genes in this network are
involved in many biological processes involved with nervous system development and
signaling pathways, reinforcing the importance of nervous system development that was
observed in the individual experiments described previously.
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Figure 5.1. Genetic interaction network of significant genes for cocaine and
methamphetamine exposed flies from GWAS, xQTL, and single-cell RNA
sequencing data. Genetic network with computationally recruited genes
constructed from common genes from GWAS, xQTL and single-cell RNA
sequencing data. The network consists of 153 interconnected genes (80
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computationally recruited, P < 0.001). Blue nodes indicate genes that were
common amongst the GWAS, xQTL, and single-cell experiments. Red nodes
indicate computationally recruited genes.

One major finding from these experiments is that the correlation structures of
consumption traits and preference for cocaine and methamphetamine are distinct from
each other. The results from the experiments described in chapter II emphasize that
consumption traits are highly correlated with one another, across sexes and treatments,
especially for naïve consumption. Conversely, consumption traits are weakly correlated
with preference phenotypes. Additionally, preference phenotypes are weakly to
moderately correlated with one another across sexes, depending on the particular trait.
However, preference traits are weakly correlated across treatments. These results
demonstrate that the underlying genetic architecture for consumption of cocaine and
methamphetamine is different than preference for cocaine and methamphetamine.

This research lays the groundwork for future directions in the field, particularly for
experiments utilizing Drosophila melanogaster. The findings from the single-cell
experiment highlight the importance of multiple brain regions in the response to cocaine.
However, this experiment was only done in one genetic background. Brain morphology
varies across genetic backgrounds leading to variation in behaviors such as aggression
and sleep (Zwarts et al., 2015), and could lead to variation in psychostimulant response
as well. To address this, single-cell RNA sequencing could be performed on a subset of
the DGRP lines to assess transcriptional differences across genetic backgrounds. This
would allow for detection of expression QTLs because the genomes of all DGRP lines

178

are fully sequenced. Another potential direction is to approach the question of cell-type
specific changes in the brain following cocaine exposure and apply the same
methodology to methamphetamine exposure.

The experiments previously discussed looked at natural genetic variation and
transcriptome changes following exposure to cocaine and methamphetamine but failed
to address the contribution of epigenetic factors including genome structure and
chromatin accessibility. With advancements in technology, researchers can now utilize
single-cell technologies to interrogate epigenetic changes at single-cell resolution using
single-cell ATACseq. This would allow for detection of chromatin accessibility across the
genome following exposure to cocaine or methamphetamine, hinting at transcriptionally
active sites throughout the genome immediately following exposure. Additionally,
proteomics and metabolomics have been previously investigated in the DGRP
previously (Okada et al., 2016; Zhou et al., 2020) and could be investigated following
exposure to cocaine or methamphetamine, focusing particularly on the brain. Integration
of these layers of data (genome, transcriptome, epigenome, metabolome, proteome)
would provide a deeper understanding of the larger picture of the genetic architecture
and biological response to cocaine and methamphetamine use. This information could
help provide potential targets for future mammal studies and as potential therapeutic
targets.

Lastly, the data gathered from the aforementioned experiments could be taken and
compared more extensively to the human and rodent literature via meta-analyses.
Studies comparing animal models directly to humans have been done previously (Diego
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& Yiemy, 2020) to discover candidate genes that are supported by multiple lines of
genomic evidence. To date, this is a technique that has not been performed often in the
drug abuse field, and not at all using flies and humans. Using convergence of multiple
lines genome-wide evidence would help identify additional candidate genes and
pathways for cocaine and methamphetamine use. These candidates would be of
particular interest to study further and validate across multiple models.

The purpose of the aforementioned experiments was to utilize Drosophila melanogaster,
a well-characterized model for genomic studies, to uncover evolutionarily conserved
genetic underpinnings of cocaine and methamphetamine use that cannot easily be
obtained using human or other mammal models. One limitation for experiments using
mammals is they contain relatively low sample numbers and decreased power in
genomic analyses. Additionally, their larger size limits the number of tissues or brain
regions that can be studied without increasing the cost substantially. By using
Drosophila melanogaster, we overcame these limitations, identifying and validating
numerous genes that are associated with increased consumption of and preference for
cocaine and methamphetamine. We also were able to and by investigating the effects of
cocaine and methamphetamine on pools of entire brains. We identified and validated
genes with human orthologs that are associated with increased consumption and
preference that were not previously implicated in cocaine and methamphetamine
response. Additionally, we uncovered specific tissues that bolster these effects including
specific neuron types and brain regions such as the mushroom body and glial cells of
the brain. We performed the first single-cell RNA sequencing experiment in flies utilizing
psychostimulants. This lays the groundwork for future studies in flies utilizing additional
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genetic backgrounds or different drugs of abuse to see how the effects of cocaine and
methamphetamine vary across genetic background and how the response to cocaine
and methamphetamine compares to other drugs of abuse. Additionally, the findings from
these experiments can serve as blueprints for subsequent studies in rodent models and
humans.
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Appendix A
Supplemental Figures

S2.1 Fig. P-value summary from three-way ANOVA models of consumption
for UAS-RNAi and control genotypes of candidate genes crossed to a weak
ubiquitous GAL4 driver (Ubi156-GAL4). Red: P < 0.0001; orange: P < 0.001;
yellow: P < 0.01; green: P < 0.05; white: P > 0.05.
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S2.2 Fig. Differences between Ubi156-GAL4 RNAi and control genotypes
for 34 candidate genes. (A) Cocaine preference, females. (B) Cocaine
preference, males. (C) Change in cocaine preference between third and first
exposures, females. (D) Change in cocaine preference between third and first
exposures, males. Asterisks represent significant L×S terms (A, B) or significant
L×S×E terms from the full ANOVA models. Exact P-values are given in S2.10
Table.
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S2.3 Fig. Differences between Ubi156-GAL4 RNAi and control genotypes
for 34 candidate genes. (A) Methamphetamine preference, females. (B)
Methamphetamine preference, males. (C) Change in methamphetamine
preference between third and first exposures, females. (D) Change in
methamphetamine preference between third and first exposures, males.
Asterisks represent significant L×S terms (A, B) or significant L×S×E terms from
the full ANOVA mod- els. Exact P-values are given in S2.11 Table.
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S2.4 Fig. P-value summary from three-way ANOVA models of consumption
for UAS-RNAi and control genotypes of candidate genes crossed to
neuronal (elav-GAL4) and glial (repo- GAL4) GAL4 drivers. Red: P < 0.0001;
orange: P < 0.001; yellow: P < 0.01; green: P < 0.05; white: P > 0.05.
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S2.5 Fig. P-value summary from three-way ANOVA models of consumption
for UAS-RNAi and control genotypes of candidate genes crossed to
mushroom body (201Y-GAL4) and dopaminergic (TH-GAL4) GAL4 drivers.
Red: P < 0.0001; orange: P < 0.001; yellow: P < 0.01; green: P < 0.05; white: P >
0.05.
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Fig. S3.1. Dose responses for cocaine and methamphetamine consumption
in the AIP. To determine the optimally discriminating concentrations of cocaine
and methamphetamine, we tested consumption of 0.05, 0.1, 0.2, 0.3, 1.0 and 3.0
µg/µL cocaine and 0.05, 0.1, 0.2, 0.3, 1.0 and 3.0 µg/µL methamphetamine for
50 males and 50 females from the AIP. The y-axes represent the average
consumption for all flies for each concentration. An S curve was superimposed to
determine the approximate inflection point. For all four sex/treatment
combinations the inflection point falls closest to a concentration of 1.0 µg/µL.
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Fig. S3.2. Distribution of consumption in the AIP. We tested the consumption
of two replicates of 1500 males and 1500 females for cocaine,
methamphetamine, and sucrose. The distribution of consumption for all
treatments in both sexes is right skewed.
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Fig. S3.3. Proboscis Extension Response (PER). (A) The PER was tested for
cocaine and methamphetamine in 100 AIP males and 100 AIP females. For
cocaine, 88% of females and 85% of males extended their proboscis. For both
sexes, 91% of flies extended their proboscis for methamphetamine. There is a
significant reduction in PER for both sexes and drugs (Chi-square test, P < 0.05)
compared to sucrose. (B) We tested consumption and PER of cocaine or
methamphetamine in males and females from the AIP to determine if the
propensity for PER correlates with the previous amount of drug consumed.
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Fig. S3.4. Extreme QTL (xQTL) mapping analysis. We performed tests for
significant differences in allele frequencies between pools of high consuming and
random control flies for 2,568,908 SNPs, separately for each treatment and sex.
The Manhattan plots show the -log10P transformed P-values for all SNPs. The xaxes show the chromosome locations for each SNP. The dashed lines represent
the Bonferroni-corrected significance level (P = 1.95 × 10-8). Dark red and dark
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blue dots represent SNPs with a significant difference in allele frequency
between control and high consuming pools in females and males, respectively.

Fig. S3.5. Genetic interaction network for significant genes for high
consumption and preference for cocaine or methamphetamine. We
compiled the significant genes from the current study with those from Ref. 20 and
constructed a genetic interaction network that consists of 197 interconnected
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genes (P < 0.001) using Cytoscape 3.8.0. Blue nodes indicate genes with a
human ortholog (DIOPT ≥ 3).

Fig. S3.6. Allele-specific AIP testing treatments. Treatments tested for allelespecific AIPs. Green indicates the drug was tested for that SNP/gene. Black
indicates the drug was not tested.
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Figure S4.1: Visualization of gene expression patterns using UMAP
projections. Gene expression patterns of single cells (n = 86,224) from all 8 (2
♀cocaine, 2 ♀sucrose, 2 ♂cocaine, 2 ♂sucrose) samples were visualized in low
dimensional space using a graph-based, non-linear dimensionality reduction
method (UMAP). Individual dots represent each cell and the colors of the dots
represent the samples to which the cells belong.
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Figure S4.2: UMAP visualization of expression patterns for genes that
respond globally to cocaine exposure. Visualization of gene expression
patterns was performed using UMAP projections. Each dot represents a cell
within the integrated dataset from all 8 samples. The color gradients of the dots
represent the normalized and scaled expression value of the genes that respond
globally due to acute cocaine exposure in each sample group (separated based
on sex and condition). Identities of specific clusters and groups of cell types are
indicated in the Rpl41 panel A: GL - Glia, OL - Optic Lobe, AC - astrocytes,
GLMN - Glutamatergic neurons, MB - Mushroom Body, GBN - GABAergic
neurons.
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Figure S4.3: Full co-expression network analysis of DEGs from the male C16
cluster. Network constructed from Pearson Coefficient based co-expression
values calculated from scaled data of genes that were differentially expressed
(filtered for |logeFC| > 0.5, Bonferroni adjusted P value < 0.05) due to cocaine
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exposure in C16 of the male dataset. Co-expressions have been filtered using
Random Matrix Theory. The colors of the dots represent the connectivity index
derived from MCODE scores. The colors of edges represent the positive (red) and
negative (green) correlations.

Figure S4.4: MCODE Subnetworks from co-expression network analysis of
DEGs from the male C22 cluster. Network constructed from Pearson Coefficient
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based co-expression values calculated from scaled data of genes that were
differentially expressed (filtered for |logeFC| > 0.5, Bonferroni adjusted P value <
0.05) due to cocaine exposure in C22 of the male dataset. Co-expression values
have been filtered using Random Matrix Theory. (a-c) MCODE subnetworks
derived from the full network. The colors of the dots represent the connectivity
index derived from MCODE scores. The colors of edges represent the positive
(red) and negative (green) correlations.
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Appendix B

Supplemental Tables

Table S2.1. DGRP raw consumption data. (A) Cocaine experiment. (B)
Methamphetamine experiment. F: female; M: male. Refer to
Supplemental_Table_S2.1.xlsx

Table S2.2. Analyses of variance of consumption, change in consumption,
preference and change in preference of cocaine and methamphetamine.
Exposure, Sex, Solution, and their interaction are fixed effects, the rest are
random. Mixed model three-way factorial ANOVAs are given for males and
females, as well as reduced models by Exposure, Sex, and Solution. E:
Exposure; X: Sex; S: Solution; L: DGRP Line; df: degrees of freedom; MS: Type
III mean squares; F: F-ratio test; P: P-value; σ2: variance component estimate;
SE: standard error; H2: Broad sense heritability. Significant P-values are shown
in red font. (A) Cocaine experiment. (B) Methamphetamine experiment. Refer to
Supplemental_Table_S2.2.xlsx

Table S2.3. DGRP line means for all traits. (A) Cocaine experiment. (B)
Methamphetamine experiment. Means are given in mm; 1 mm = 0.067 μl. Refer
to Supplemental_Table_S2.3.xlsx
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Table S2.4. Genetic and phenotypic correlations between traits. (A) Crosssex, cross-exposure and cross-solution genetic correlations. Significant P-values
are indicated in red font. (B) Pair- wise phenotypic correlations. Entries in the
cells are the correlation coefficients and the cell color denotes the P-value. Red:
P < 0.0001; orange: P < 0.001; yellow: P < 0.01; green: P < 0.05; white: P > 0.05.
Refer to Supplemental_Table_S2.4.xlsx

Table S2.5. Results of genome wide association (GWA) analyses for
consumption behaviors. (A) Top variants (P < 5 ×10−5) and associated genes
for each trait. (B) Variants and genes for the cocaine traits, the
methamphetamine traits, and variants and genes overlapping between the two
experiments. (C) Pathway and gene ontology enrichment analysis for the cocaine
GWA analyses. (D) Pathway and gene ontology enrichment analysis for the
methamphetamine GWA analyses. Refer to Supplemental_Table_S2.5.xlsx

Table S2.6. DGRP candidate genes and human orthologs. The references
indicate which of the human orthologs have been associated with addictive
phenotypes. Refer to Supplemental_Table_S2.6.xlsx

Table S2.7. A significant genetic interaction network with no missing
genes. (A) Genes in network. (B) Human orthologs. (C) Pathway and gene
ontology enrichment analysis. Refer to Supplemental_Table_S2.7.xlsx
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Table S2.8. Raw cocaine and sucrose consumption data for RNAi and
control genotypes. (A) Ubi156-GAL4. (B) elav-GAL4. (C) repo-GAL4. (D) 201YGAL4. (E) TH-GAL4. Data are given in mm; 1 mm = 0.067 μl. Refer to
Supplemental_Table_S2.8.xlsx

Table S2.9. Raw methamphetamine and sucrose consumption data for
RNAi and control genotypes. (A) Ubi156-GAL4. (B) elav-GAL4. (C) repo-GAL4.
(D) 201Y-GAL4. (E) TH-GAL4. Data are given in mm; 1 mm = 0.067 μl. Refer to
Supplemental_Table_S2.9.xlsx

Table S2.10. Analyses of variance of consumption, change in consumption,
preference and change in preference of cocaine and sucrose in RNAi lines
and their controls. Fixed effect three-way factorial ANOVAs are given for males
and females as well as reduced models by Exposure and Solution. E: Exposure;
S: Solution; L: RNAi or control genotype; df: degrees of freedom; MS: Type III
mean squares; F: F-ratio test; P: P-value. Significant P-values are shown in red
font. (A) Ubi156-GAL4. (B) elav-GAL4. (C) repo-GAL4. (D) 201Y-GAL4. (E) THGAL4. Refer to Supplemental_Table_S2.10.xlsx

Table S2.11. Analyses of variance of consumption, change in consumption,
preference and change in preference of methamphetamine and sucrose in
RNAi lines and their controls. Fixed effect three-way factorial ANOVAs are
given for males and females as well as reduced models by Exposure and
Solution. E: Exposure; S: Solution; L: RNAi or control genotype; df: degrees of
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freedom; MS: Type III mean squares; F: F-ratio test; P: P-value. Significant Pvalues are shown in red font. (A) Ubi156-GAL4. (B) elav-GAL4. (C) repo-GAL4.
(D) 201Y-GAL4. (E) TH-GAL4. Refer to Supplemental_Table_S2.11.xlsx

Table S2.12. Drosophila lines used in this study. (A) DGRP lines. (B) RNAi
lines and control genotypes. (C) GAL4 driver lines. Refer to
Supplemental_Table_S2.12.xlsx

Table S3.1. Raw consumption data in the AIP. (A) Dose response raw
consumption values. (B) Raw consumption for the xQTL analyses. NA indicates
a consumption value outlier that may have been influenced by excessive
evaporation. Refer to Supplemental_Table_S3..1xlsx

Table S3.2. Raw PER data in the AIP. (A) PER for males and females. (B) PER
in males and females after consumption of cocaine or methamphetamine. Refer
to Supplemental_Table_S3.2.xlsx

Table S3.3. Extreme QTL (xQTL) GWA analysis in the AIP. Significant SNPs
(following Bonferroni correction for multiple tests) and their allele frequency
differences between control and high pools are given for each condition, sex, and
replicate. Annotated genes are given for SNPs within 1 kb of the gene body.
Refer to Supplemental_Table_S3.3.xlsx
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Table S3.4. Human orthologs for candidate genes from the xQTL analyses.
Refer to Supplemental_Table_S3.4.xlsx

Table S3.5. Gene Ontology (GO) enrichment analyses for candidate genes
from the xQTL analyses. (A) All candidate genes from methamphetamine and
cocaine treatments. (B) Methamphetamine consumption candidate genes. (C)
Cocaine consumption candidate genes. (D) Female methamphetamine
consumption candidate genes. (E) Male methamphetamine consumption
candidate genes. (F) Female cocaine consumption candidate genes. (G) Male
cocaine consumption candidate genes. Refer to Supplemental_Table_S3.5.xlsx

Table S3.6. Gene Ontology (GO) enrichment analysis for 77 candidate
genes from the xQTL GWA analyses that belong to a significant (P < 0.001)
genetic interaction network. Refer to Supplemental_Table_S3.6.xlsx

Table S3.7. Gene Ontology (GO) enrichment analysis for 197 genes
overlapping between the xQTL and DGRP (Ref 20) GWA analyses and that
belong to a significant (P < 0.001) genetic interaction network. Refer to
Supplemental_Table_S3.7.xlsx

Table S3.8. Raw consumption values for RNAi and control lines. Group
indicates the control line and RNAi lines that were analyzed together. NA
indicates an outlier with excessive evaporation. Refer to
Supplemental_Table_S3.8.xlsx
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Table S3.9. Full and reduced model ANOVAs for candidate genes evaluated
for consumption using RNAi. Significance codes: ***; P < 0.001; **; P <0.01; *;
P <0.05. (A) Full model pooled across sexes, methamphetamine. (B) Full model
pooled across sexes, cocaine. (C) Full model pooled across sexes, sucrose. (D)
Reduced model by sex, methamphetamine. (E) Reduced model by sex, cocaine.
(F) Reduced model by sex, sucrose. (G) Full model pooled across
methamphetamine and cocaine and sexes. (H) Full model pooled across
methamphetamine and sucrose and sexes. (I) Full model pooled across cocaine
and sucrose and sexes. Refer to Supplemental_Table_S3.9.xlsx

Table S3.10. Naming scheme for allele-specific AIPs. SNP locations are from
FlyBase Release 5.57. Refer to Supplemental_Table_S3.10.xlsx

Table S3.11. Allele-specific AIP raw consumption data. Refer to
Supplemental_Table_S3.11.xlsx

Table S3.12. Full and reduced model ANOVAs for allele specific AIPs.
Significance codes: ***; P < 0.001; **; P <0.01; *; P <0.05. (A) Full model pooled
across sexes. (B) Reduced model by sex. Refer to
Supplemental_Table_S3.12.xlsx

Table S3.13. RNAi lines. Refer to Supplemental_Table_S3.12.xlsx
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Table S3.14. Raw consumption values for the dose responses of RNAi
control lines. Refer to Supplemental_Table_S3.14.xlsx

Table S4.1: Raw behavioral data of flies exposed to cocaine. Refer to
Supplemental_Table_S4.1.xlsx
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Estimated

Mean

Median

Number of

Reads

Genes

Cells

per Cell

per Cell

87,765,954

9,072

9,674

772

72,264,746

11,693

6,180

123,911,975

13,193

114,946,639

Total

Reads in

Genes

Cells

Detected

41.60%

71.50%

11,958

1,347

807

29.70%

80.90%

12,049

1,476

9,392

769

29.20%

79.50%

12,523

1,378

11,033

10,418

799

31.10%

72.00%

12,354

1,440

120,400,905

13,072

9,211

733

22.40%

69.70%

12,203

1,304

142,640,818

9,367

15,228

1,080

52.80%

83.30%

12,618

2,286

78,416,962

10,437

7,513

680

22.00%

68.40%

11,631

1,190

162,182,108

11,124

14,579

1,207

21.70%

58.70%

12,464

2,868

Sequencing

Number of

Sample ID

Reads

♀ Sucrose
Rep 1

♀ Sucrose
Rep 2

♂ Sucrose
Rep 1

♂ Sucrose
Rep 1

♀ Cocaine
Rep 1

♀ Cocaine
Rep 2

♂ Cocaine
Rep 1

♂ Cocaine
Rep 2
Undetermin
ed

Median

Fraction

Sequencing
Saturation

UMI
Counts
per Cell

49,596,498

Total

967,684,238

88,991

Minimum

72,264,746

9,072

6,180

680

21.70%

58.70%

11,631

1,190

Maximum

162,182,108

13,193

15,228

1,207

52.80%

83.30%

12,618

2,868

Ratio

2.24

1.45

2.46

1.78

2.43

1.42

1.08

2.41

Mean

112,816,263

11,124

10,274

856

31.31%

73.00%

12,225

1,661

31,547,982

1520.21

3156.57

185.07

10.91%

8.02%

332.22

592.64

Standard
deviation

Table S4.2: Summary of sequencing and alignment statistics.
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Table S4.3: Differentially expressed genes after cocaine exposure of males
and females and their top human orthologs. Refer to
Supplemental_Table_S4.3.xlsx
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Table S4.4: Characterization of cell clusters through combinations of
biomarkers. Genes indicated in bold font were used to annotate the clusters.

Table S4.5: Genes that were consistently upregulated and downregulated
across multiple clusters due to acute cocaine exposure. Refer to
Supplemental_Table_S4.5.xlsx

Table S4.6: Results from differential expression analysis for each cluster
from the male and female datasets combined. Refer to
Supplemental_Table_S4.6.xlsx
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Table S4.7: Results from differential expression analysis for each cluster
from the male dataset. Refer to Supplemental_Table_S4.7.xlsx

Table S4.8: Results from differential expression analysis for each cluster
from the female dataset. Refer to Supplemental_Table_S4.8.xlsx

Table S4.9: Quantification of shared and unique differentially expressed
genes due to exposure to cocaine between the males and females within
each cluster. Refer to Supplemental_Table_S4.9.xlsx

Table S4.10: Functional enrichment analyses of differentially expressed
genes in selected clusters due to cocaine exposure. Refer to
Supplemental_Table_S4.10.xlsx
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Appendix C

Supplemental Methods and References

Methods

Cocaine exposure

Cocaine.HCl was obtained from the National Institute on Drug Abuse under Drug
Enforcement Administration license RA0443159. To expose flies to cocaine, we
performed a modified version of the capillary feeder (CAFÉ) assay (Ja et al. 2007). We
collected 200 Canton S (B) flies between 3 and 5 days old using CO2 anesthesia, sexes
separately. We placed them individually in culture vials containing
cornmeal/yeast/molasses/agar culture medium (Genesee Scientific, Inc., San Diego,
CA) and allowed them to recover for 24 hours before experimentation. Between 3:005:00 PM on the day before the assay, we transferred the flies to vials containing 1.5%
agar (Sigma Aldrich, St. Louis, MO) in which a capillary (VWR International, Radnor, PA:
12.7 cm long, 5 μl total volume) filled completely with a solution of 4% sucrose (Sigma
Aldrich) and 1% yeast (Fisher Scientific, Hampton, NH) was inserted. The next morning,
we replaced the sucrose capillaries for 100 flies with capillaries containing 4% sucrose
supplemented with 1 µg/µL of cocaine and 1% yeast; for the other 100 flies, we replaced
the sucrose capillaries with fresh 4% sucrose and 1% yeast with no drug. A droplet of
mineral oil (Sigma Aldrich) was added to the top of each capillary to minimize
evaporation. We collected the first 40 flies that consumed 0.53 µL of cocaine and the
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first 40 flies that consumed 0.53 µL of sucrose, corresponding to an 8 mm reduction in
the height of the solution in the capillary. All experiments were carried out between 8 AM
and 11 AM. Flies were allowed to feed for no more than 2 hours.

Behaviors

We measured negative geotaxis and startle response of individual flies within a 10minute time-frame immediately following acute exposure to cocaine in the CAFÉ assay.
We quantified grooming and seizures in addition to measuring the behavioral response
in each assay. Excessive grooming was defined as more than 10 seconds of constant
grooming (Video S4.2). Seizure activity was defined as severe muscle tremors that
prevented the fly from moving normally (Video S4.3).

Negative geotaxis

Following acute cocaine consumption, we placed each fly in a 14.8 cm-tall clear glass
vial with its circumference marked 7.5 cm up the vial. Flies were given 30 seconds to
acclimate to the vials. We then tapped the flies to the bottom of the vial and recorded the
time taken for each fly to cross the 7.5 cm mark, with a maximum allowed climb time of
30 seconds. Flies that did not pass the mark within 30 seconds were designated as “did
not finish”. The numbers of flies tested are indicated in the legend to Figure 1.
Significant differences from control were assessed using one-tailed Student’s t-test.
Grooming and seizure activity were also scored at this time and differences between
control flies and flies exposed to cocaine were assessed using Fisher’s exact test.
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Startle response

Following acute cocaine consumption, we tested single flies in their vials for acute startle
response. To ensure the same amount of mechanical stimulation for all trials, we
constructed a ‘fly drop tower’ in which all vials were dropped 42 cm and then secured in
a horizontal position. As soon as the vials attained a horizontal position the flies were
observed for 45 seconds and the total time each fly spent moving was recorded (Video
S4.1). The numbers of flies tested are indicated in the legend to Figure 1. Significant
differences from control were assessed using one-tailed Student’s t-test. Grooming and
seizure activity were also scored at this time and differences between control flies and
flies exposed to cocaine were assessed using Fisher’s exact test. While grooming, flies
were stationary.

Brain dissection and dissociation

Brains were dissected from each fly immediately after it consumed the designated
amount of sucrose or cocaine solution. We used a dissociation protocol modified from
Croset et al. (2018) and Davie et al. (2018). We dissected brains in cold D-PBS (Gibco,
Thermo Fisher Scientific, Waltham, MA) and collected them into 1.7 ml tubes in cold
Schneider’s medium (Gibco). We collected 20 brains per sample within one hour. We
collected eight samples of 20 brains from males and females exposed to cocaine or
sucrose, with two biological replicates per treatment and sex. We replaced the D-PBS in
the dissection dish after dissecting 2 brains to ensure that it stayed cold and we used
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separate drops of buffer for decapitation and brain dissection to avoid contaminating the
brain samples. We centrifuged the samplesn at 300xg at 4oC for 5 min and removed the
supernatant. We then added 450µl of collagenase solution (50 ul of fresh 25mg/ml
collagenase (Gibco) in sterile water + 400µl of Schneider’s medium), flicked the tube
gently and allowed the brains to incubate at room temperature for 30 min. We replaced
the collagenase solution after centrifugation with PBS + 0.04% BSA (NEB, Ipswich, MA).
We mechanically dissociated the brains slowly and gently, using stepwise trituration P200 pipette 5 times, 23G needle pre-wetted with PBS + BSA 5 times, and 27G prewetted needle 5 times. We passed the suspension through a pre-wetted 10µm strainer
(Celltrics, Görlitz, Germany) aided by gentle tapping. We added 50ul of PBS+BSA to aid
flow of the suspension through the strainer. We counted live cells using a
hemocytometer with trypan blue exclusion. We proceeded with GEM generation using
the Chromium controller (10X Genomics, Pleasanton, CA) if we had a live cell count of >
500 live cells/µl.

Library preparation and sequencing

We made libraries after GEM generation in accordance with 10X Genomics v3.1
protocols. We determined fragment sizes using Agilent Tapestation kits (Agilent, Santa
Clara, CA) - d5000 for amplified cDNA and d1000 for libraries. However, the samples
were not diluted at either step since these were not high concentration libraries. We
measured the concentrations of amplified cDNA and the final libraries using a Qubit 1X
dsDNA HS kit, also without dilution. In addition to Qubit, we quantified the final library
concentrations using a qPCR based library quantification kit (KAPA Biosystems, Roche,
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Basel, Switzerland) in order to measure the concentration of fragment sizes of interest in
accordance with the manufacturer’s recommendations. We used 12 cycles for the cDNA
amplification and 14 cycles for indexing PCR. We sequenced the final libraries on an S1
flow cell using a Novaseq (Illumina, Inc., San Diego, CA) according to the
manufacturer’s instructions.

FASTQ generation, demultiplexing and alignment

The mkfastq pipeline within Cell Ranger v3.1 (10X Genomics, Pleasanton, CA) was
used to convert BCL files from the sequence run folder to demultiplexed FASTQ files.
Release 6 version of the Drosophila melanogaster reference GCA_000001215.4 from
NCBI Genbank was indexed using the mkref pipeline and used for alignment using the
count pipeline within Cell Ranger v3.1 with the expected cell count parameter set to
5,000 cells. The sequencing and alignment summary is given in Supplemental Table S2.

Preprocessing, integration and cell-type clustering

Raw expression counts output for each sample from the Cell Ranger pipeline was
imported and analyzed using the Seurat v3 package in R (Butler et al. 2018). Genes
expressed in less than 5 cells and cells with less than 300 or greater than 2500 RNA
features were filtered out. Normalization and subsequent integration were performed
using scTransform pipeline (Hafemeister and Satija, 2019). To identify the cell-type
clusters within the dataset, unsupervised clustering using the FindClusters function and
a resolution of 0.8 was used. Cluster marker genes were identified using FindAllMarker
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function (min.pct=0.25, logfc.threshold = 0.5, only.pos = TRUE).The top three genes
with positive expression for each cluster were extracted and used for cell-type
characterization.

Differential expression

Differential expression was performed for each cluster in two ways: (i) after combining
male and female samples together to test for effects of cocaine that are common to both
sexes; and (ii) testing for effects of cocaine in males and females separately to identify
sexually-dimorphic responses. The Pearson residuals output from scTransform pipeline
was used as input for differential expression (DE) calculation (Hafemeister and Satija,
2019). The MAST algorithm was used as the testing methodology in the FindMarkers
function (test.use = "MAST", assay = "SCT", slot = "scale.data") for each cluster to
calculate DE. Clusters with sufficient number of DEGs were subjected to pathway
enrichment analysis using the statistical overrepresentation test using the PantherDB
(Thomas et al. 2003) and Reactome databases (Fabregat et al. 2016). Pathways with
BH-FDR adjusted P values < 0.05 were considered statistically enriched.

Simulation of bulk RNAseq response

The results from DE calculation from the combined dataset were used to determine
which genes were consistently upregulated and downregulated, respectively, across all
clusters as a result of exposure to cocaine. The top 50 ranked differentially upregulated
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genes for each cluster and the top 20 ranked differentially downregulated genes for each
cluster were input into TopKLists R package (Schimek et al. 2015).

Cluster-specific co-expression networks

The scaled data from the scTransform pipeline for differentially expressed genes from
clusters 16 and 22 were extracted for the male samples. These scaled data were used
as input for filtering through Random Matrix Theory (RMT; Gibson et al. 2013). The
correlations that passed the filtering process were visualized using Cytoscape version
3.7.2. The MCODE algorithm (Bader and Hogue 2003) was utilized to identify highly
interconnected modules within the larger cluster network. Genetic interaction networks
were constructed by converting the gene IDs to gene names/symbols using the FlyBase
Consortium’s ‘Query-by-symbols/ID’ tool and calculating interactions between gene
products using the stringApp plugin within Cytoscape (Doncheva et al. 2019). To
identify specific pathways that are enriched in genes within each of the circular groups,
we performed statistical overrepresentation tests on the gene IDs from each group using
the PantherDB (Thomas et al. 2003) and Reactome (Fabregat et al. 2016) databases.
Pathways with BH-FDR adjusted P values < 0.05 were considered statistically enriched.
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Appendix D

Supplemental Movies

Movie S1: Startle response assay. Refer to Supplemental_Movie_S1.mp4

Movie S2: Grooming behavior of a male exposed to cocaine. Refer to
Supplemental_Movie_S2.mp4

Movie S3: Seizure of a male exposed to cocaine. Refer to
Supplemental_Movie_S3.mp4
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